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ABSTRACT 
 
PRESENTACIÓN 
ABSTRACT 
 
DNA replication must be precisely regulated to ensure faithful inheritance of genetic 
information. In mammalian cells, the process of genomic duplication starts from 
thousands of replication origins. During G1, the Origin Recognition Complex (ORC), 
CDC6 and CDT1 proteins cooperate to engage the MCM helicase complex at the 
origins. This process is called ‘origin licensing’ and renders cells competent to initiate 
DNA replication in the subsequent S phase. After the S phase starts, initiator proteins 
are inhibited to prevent origin re-licensing and reactivation. If this control is overridden, 
cells undergo aberrant DNA re-replication, which causes DNA damage, genomic 
instability and even cell death. The effects of DNA re-replication have been mainly 
studied in cells in culture, but not in mammalian organisms in vivo.  
 
In the first part of this Thesis we have studied the consequences of CDC6 and CDT1 
deregulated expression in mice. We have identified a limiting role for CDC6 in origin 
licensing and activity. We have also found that both CDC6 and CDT1 need to be 
overexpressed in combination to induce re-replication in primary MEFs and adult 
tissues. Highly proliferative cells, including embryonic stem cells and hematopoietic 
precursors showed a marked susceptibility to CDT1 overexpression, which correlated 
with high expression of endogenous CDC6. In the mouse, DNA re-replication caused 
severe tissue dysplasias that become lethal in less than 2 weeks. 
 
In the second part of the Thesis we have carried out a genetic screening to find new 
mechanisms that control the extent of re-replication caused by origin refiring. We have 
identified FBH1 and RAD51 as members of a new pathway that limits this aberrant 
process. RAD51 binds to chromatin in S phase and acts as a molecular brake to hinder 
progression of re-replication forks. This role depends on the binding of RAD51 to DNA 
around the origins but is independent of homologous recombination. Finally, we have 
found that MRE11 nuclease might be also involved in this process by catalyzing the 
resection of re-replicated DNA.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PRESENTACIÓN 
 
A fin de asegurar la transmisión del material genético, la replicación del DNA está 
regulada de manera precisa para que ocurra una única vez en cada ciclo celular. En 
células de mamífero, la duplicación comienza en miles de puntos del genoma conocidos 
como ‘orígenes de replicación’. En la fase G1, las proteínas iniciadoras ORC, CDC6 y 
CDT1 cooperan para ‘cargar’ la helicasa MCM en los orígenes, un proceso conocido 
como “licenciamiento”. Tras el inicio de la fase S, estas proteínas son inhibidas para 
evitar la reactivación de orígenes que conduce a la re-replicación, un proceso aberrante 
que causa daños en el DNA, inestabilidad genómica y muerte celular. Los efectos de la 
re-replicación han sido muy estudiados en sistemas celulares, pero no en organismos 
mamíferos in vivo. 
 
En la primera parte de esta Tesis se han estudiado las consecuencias de la sobre-
expresión de las proteínas CDC6 y CDT1 en ratones. Hemos encontrado un papel 
limitante de CDC6 en el licenciamiento y la actividad de los orígenes. También hemos 
encontrado que la desregulación conjunta de CDC6 y CDT1 induce re-replicación en 
células primarias y algunos tejidos adultos. En células con alta tasa de proliferación, 
como las células madre embrionarias y los precursores hematopoyéticos, la sobre-
expresión de CDT1 es suficiente para causar re-replicación, probablemente debido a sus 
elevados niveles endógenos de CDC6. In vivo, la re-replicación causa displasias en 
varios tejidos y resulta letal en menos de dos semanas. 
 
En la segunda parte de la Tesis se ha desarrollado un screening genético para detectar 
nuevos mecanismos que bloqueen la re-replicación. FBH1 y RAD51 han sido 
identificados como componentes de una nueva vía que limita dicho proceso. RAD51 se 
une a la cromatina durante la fase S y actúa como ‘freno molecular’ para bloquear la 
progresión de las horquillas re-replicadas. Este papel depende de la unión de RAD51 al 
DNA pero es independiente de la recombinación homóloga. Además, la nucleasa 
MRE11 podría estar implicada en esta vía a través de la resección del DNA re-
replicado. 
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ABBREVIATIONS 
 
 
Aph  Aphidicolin 
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BIR  Break-induced replication 
 
BM  Bone marrow 
 
BrdU  5-bromo-2'-deoxyuridine 
 
C1  CDT1 
 
C6  CDC6 
 
CDK  Cyclin-Dependent Kinase 
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CldU  5-Chloro-2’-deoxyuridine 
 
CMG  CDC45-GINS-MCM 
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DAPI  4',6-diamidino-2-phenylindole 
 
DDK  Dbf4-Dependent Kinase 
 
DDR  DNA damage response 
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dNTP  Deoxyribonucleotide triphosphate 
 
DSBs  Double strand breaks 
 
dsDNA double strand DNA 
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 10 
 
ESCs  Embryonic stem cells 
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FACS  Fluorescence activated cell sorting 
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HSCs  Hematopoietic stem cells 
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ICL  Inter-strand crosslink 
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IHC  Immunohistochemistry 
 
IOD  Inter-origin distance 
 
IP  Immunoprecipitation 
 
iPOND isolate proteins on nascent DNA 
 
MEF  Mouse embryonic fibroblast 
 
NAHR  Non-allelic homologous recombination 
 
NER  Nucleotide excision repair 
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NHEJ  Non-homologous end-joining 
 
ns  non significant 
 
o/e  overexpression 
 
PFA  Paraformaldehyde 
 
PI  Propidium iodide 
 
preIC  pre-Initiation complex 
 
preRC  pre-Replicative complex 
 
R26  Rosa 26 locus 
 
RS  Replicative stress 
 
rtTA  tetracycline-responsive element 
 
RT-qPCR Retrotranscription and quantitative PCR 
 
shRNA short hairpin RNA 
 
siRNA  short interfering RNA 
 
SNS  Short nascent strands 
 
SSA  Single strand annealing 
 
ssDNA single strand DNA 
 
Tg  Transgenic 
 
Thy  Thymidine 
 
TLS  Translesion synthesis 
 
TMRE  Tetramethylrhodamine ethyl ester 
 
TPA  12-O-tetradecanoylphorbol 13-acetate 
 
TS  Template switching 
 
UTR  Untranslated region 
 
UV  Ultraviolet 
 
WT  Wild type 
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INTRODUCTION 
 
DNA replication and replication origins 
Proliferating cells duplicate their entire genome during the S phase of the cell cycle 
before each mitotic division. In eukaryotes, the process of genomic duplication starts 
from thousands of points in the genome called replication origins. A precise regulation 
over origin activity is required to maintain genomic stability and to ensure the faithful 
transmission of genetic information. Deregulated DNA replication has been linked to 
DNA damage, genomic instability and cancer (reviewed by Arias and Walter 2007; 
Blow and Gillespie, 2008; Hills and Diffley, 2014; Muñoz and Mendez, 2016). 
 
Whereas in the budding yeast Saccharomyces cerevisiae replication origins are defined 
by specific, autonomously-replicating sequences (ARS) in the DNA, in higher 
eukaryotes, origins are rather defined by chromatin states and/or epigenetic marks 
(reviewed by Fragkos et al, 2015; Prioleau and MacAlpine, 2016). Origins may contain 
G-rich sequences (Cayrou et al, 2011; 2012; Besnard et al 2012) capable of forming G-
quadruplexes (G4) that could influence nucleosome positioning (Cayrou et al; 2015) 
and/or be specifically recognized by initiator proteins (Hoshina et al, 2013; Keller et 
al, 2014). 
 
Replication origin activation is also related to gene transcription (Cadoret et al, 2008). 
Indeed, replication origins have been identified at CpG islands and other gene 
regulatory elements with open chromatin structure. Several studies have shown a high 
correlation between replication origins and DNase I-accesible chromatin. Actually, it 
has been suggested that the strongest origins, i.e. those with higher probability of firing 
or those that are conserved in different cell types, are located at CpG islands and open 
chromatin structures (Cadoret et al, 2008; Miotto et al, 2016; Sequeira-Mendes et al, 
2009; Besnard et al, 2012). In addition, replication origins and their surroundings are 
enriched in epigenetic marks corresponding to open chromatin, such as H3K9ac, 
H3K4me3, H3K79me2 and H3K20me2 (Fu et al 2013; Picard et al, 2014). It has been 
proposed that tethering the PR-Set7 methyltransferase to DNA is sufficient to define a 
new origin (Tardat et al, 2010). In contrast, other epigenetic marks such as H4 
acetylation are not sufficient to define an origin, but could be related to origin efficiency 
(Miotto and Struhl, 2010). 
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Spatially, replication origins are organized in higher structures called “replication 
factories” (Nakamura et al, 1986; Jackson and Pombo, 1998; reviewed by Berezney et 
al, 2000). A replicon is defined as the length of DNA that is duplicated from a single 
origin, although other origins may exist and remain silent. Replication factories harbour 
a cluster of origins that activate synchronously (Huberman and Riggs, 1968; Berezney 
et al, 2000) and they can be visualized as discrete foci in the nucleus by the detection of 
nucleotide analogues incorporated onto newly synthesized DNA (Stubblefield, 1975). 
The cohesin complex plays a role in stabilizing the DNA loops between adjacent origins 
in a replication factory (Guillou et al, 2010). Organization of replication origins in 
factories facilitates their simultaneous activation and their regulation under special 
stress situations (see below).  
 
Origin activation  
Activation of replication origins is tightly regulated to ensure that DNA is copied only 
once in each cell cycle. Origins are activated in two steps. First, an “origin licensing” 
step in G1 that consists in the loading of proteins with helicase activity onto the DNA. 
This is followed by “origin firing” in S phase that involves the activation of the 
helicase and initiation of DNA synthesis (Fig 1; reviewed in Deegan and Diffley, 2016). 
 
Origin Licensing 
Eukaryotic origins are recognized by initiator proteins called ORC (Origin Recognition 
Complex), CDC6 (Cell Division Cycle 6) and CDT1 (Cdc10-Dependent Transcript 1), 
whose function is to attract and engage the MCM2-7 (Mini-Chromosome Maintenance) 
hexameric complex with the DNA. The resulting structure is referred to as pre-
replicative complex (pre-RC). MCM2-7 forms the core of the replicative helicase, 
which will be activated in S phase (reviewed by Deegan and Diffley, 2016) (Fig 1).  
 
ORC is a hexameric AAA+ ATPase that binds to origins during the entire cell cycle 
(Bell and Stillman, 1992). It works as a platform for the binding of CDC6, another 
AAA+ ATPase (Speck et al 2005). At least in yeast, CDT1, a protein with a chaperone 
function, binds to MCM2-7 to form a heptameric complex (Takara and Bell, 2011). 
ORC and CDC6 cooperate to recruit CDT1-MCM2-7 to origins to form the pre-RC in a 
reaction dependent on their ATPase activities (Randell et al, 2006). 
 17 
 
 
MCM2-7 complex is a ring-shaped planar heterohexamer in which each subunit 
contains an N-terminal interacting domain and a C-terminal AAA+ ATPase domain. 
The ATPase sites are configured at the interphase between two subunits, one of them 
providing the Walker A and B motifs to bind ATP and the other one providing an 
“Arginine finger” element required for ATP hydrolysis (Fletcher et al, 2003; Costa et al 
2013; Li et al, 2015). MCM2-7 is loaded in an inactive form as a double head-to-head 
hexamer that encircles dsDNA (Ervin et al, 2009; Remus et al, 2009). The interphase 
between the MCM2 and MCM5 subunits configures a steric gate to open and close the 
MCM2-7 complex around dsDNA (Samel et al, 2014). Then, DNA and ATP binding 
may induce structural changes to promote a closer conformation (Hesketh et al, 2015; 
Boskovic et al, 2016). Interestingly, MCM complexes can translocate passively on the 
DNA and move away from the origins (Powel et al, 2015).  
 
The multi-step pathway of MCM loading has been recently investigated in detail 
(Fernández-Cid et al, 2013; Frigola et al, 2013; Coster et al, 2014; Kang et al, 2014; 
Yeeles et al, 2015). It starts with the formation of an OCCM (ORC-CDC6-CDT1-
MCM) complex (Fernández-Cid et al, 2013). If any component of this complex is 
missing or if ORC has been inactivated, CDC6 ATPase activity induces complex 
disassembly (Frigola et al, 2103). However, if the complex is formed correctly, ORC 
and CDC6 ATPase activities promote CDT1 release and the formation of the OCM 
FIGURE 1. Replication origin 
activation pathway. In the G1 
phase, ORC, CDC6 and CDT1 
cooperate to load a double MCM 
complex hexamer. At S phase, 
CDK and DDK activities 
phosphorylate different proteins 
(Sld2, Sld3, TopBP1 and MCMs) 
to promote the loading of CDC45 
and GINS complex, activating the 
CMG helicase. The binding of 
polymerases and accessory 
components configure the 
replisome to initiate bidirectional 
DNA replication. 
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(ORC-CDC6-MCM) complex (Fernández-Cid et al, 2013). It has also been proposed 
that ATP hydrolysis by MCM complex leads to CDT1 release (Coster et al, 2014; Kang 
et al, 2014). Loading of the second MCM hexamer is less well understood but it 
requires the interaction between CDC6 and MCM3 (Frigola et al; 2013) as well as a 
second molecule of CDC6 (Ticau et al, 2015). 
 
Origin Firing 
At the onset of S-phase, CDK (Cyclin-Dependent Kinase) and DDK (Dbf4-Dependent 
Kinase) activities promote the binding of CDC45 and GINS proteins to MCMs, forming 
the CMG (CDC45-GINS-MCM) holo-enzime. CMG is the active helicase that unwinds 
DNA, a necessary step to initiate bidirectional replication from each origin (Tognetti et 
al, 2014; Fig 1). At least in yeast, additional factors are needed to activate the helicase: 
Sld2, Sld3/7, Dpb11, DNA polymerase  and Mcm10 (Yeeles et al, 2015). Sld2 and 
Sld3 are the only essential targets of CDKs and their phosphorylation promotes their 
binding to Dpb11 (Tanaka et al, 2007; Zegerman and Diffley, 2007). Sld2 
phosphorylation promotes GINS and Pol recruitment to the origin (Muramatsu et al; 
2010) while Sld3 facilitates Cdc45 binding to MCM2-7 (Nakajima et al, 2002; Tanaka 
et al, 2010). This regulation is maintained in higher eukaryotes through RecQL4, 
Treslin and TopBP1, the Sld2, Sld3 and Dpb11 homologues, respectively (Sangrithi et 
al, 2005; Im et al, 2009; Kumagai et al, 2010; 2011; Boos et al, 2011). In turn, the main 
target for DDK seems to be the MCM complex (Sheu and Stillman, 2006). 
Phosphorylation of MCM2, 4 and 6 appear to be necessary to activate the complex 
(Francis et al, 2009; Sheu and Stillman, 2010). Regarding MCM10, its precise 
biochemical activity is not clear but it facilitates Pol association with the replisome 
and DNA unwinding (Kanke et al 2012; van Deursen et al 2012). 
 
DNA synthesis initiates with the assembly of the ‘replisome’ complex (Fig 2) and the 
establishment of two ‘replication forks’ that move bidirectionally from each origin. The 
replisome is composed by multiple proteins including three DNA polymerases (, , 
and ), the processivity factor PCNA (Proliferating Cell Nuclear Antigen), Ctf4 and the 
so-called ‘replication pausing complex’ (Tipin, Tim1, And1 and Claspin) that tethers 
the DNA polymerases to the helicase (Gambus et al, 2006; 2009; Errico et al, 2009). 
 19 
 
 
Origin activation: once and only once in each cell cycle 
Origin licensing and firing are separated in two different phases to ensure a single round 
of DNA replication in each cell cycle (reviewed in Arias and Walter, 2007). During S 
phase, origin licensing is inhibited because the same signals that promote origin 
activation inhibit the activity of initiator proteins (Fig 3A). In this way, origin 
relicensing is prevented during S and G2 phases. Cell cycle oscillations of CDK activity 
are a key component of this strategy, and additional mechanisms reinforce this control 
(see below). The ubiquitin ligase APC (Anaphase Promoting Complex) and its cofactors 
Cdc20 and Cdh1 target cyclins for degradation providing a window of low CDK 
activity in G1 that allows the licensing of all potential origins (Fig 3B). Following APC 
inactivation, CDK activity is increased in S phase, promoting both origin firing and 
initiator proteins inhibition (Fig 3A, B). 
 
The inability to assemble new pre-RC during S phase represents a risk if replication 
forks are paused, blocked or inactivated in any way. For this reason, G1 cells license an 
excess of replication origins that remain in a ‘dormant’ state (Ge et al. 2007; Ibarra et al. 
2008). Activation of these dormant origins is likely the main mechanism to restore 
replication after fork stalling in higher eukaryotes (Petermann and Helleday, 2010). This 
and other mechanisms will be presented in more detail in the section “Replication 
stress”. 
 
FIGURE 2. Structure of eukaryotic 
replisome (taken from Alabert & 
Groth. 2012). CMG complex, DNA 
polymerases, PCNA, Replication 
Factor C (RFC) and the replication 
pausing complex (Tipin, Tim1, And1 
and Claspin) are shown. 
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If origins could be relicensed during S or G2, when origin firing is favoured, relicensed 
origins would easily be reactivated, giving rise to partial DNA re-replication. 
 
 
 
 
DNA re-replication 
Re-replication has been detected in several eukaryotic organisms when one or more 
components of pre-RC are deregulated (Nguyen et al, 2001; Vaziri et al, 2003; 
Melixetian et al, 2004; Green et al, 2006; Sugimoto et al, 2009). It leads to replication 
stress (RS) and DNA damage, monitored by single strand DNA accumulation 
(Melixetian et al, 2004; Zhu and Dutta, 2006; Liu et al, 2007; Neelsen et al, 2013) and 
DNA double strand breaks (DSBs) (Zhu and Dutta, 2006; Lovejoy et al, 2006; 
Davidson et al, 2006; Neelsen et al, 2013). Activation of the G2/M checkpoint prevents 
cells with re-replicated DNA from entering mitosis and abrogation of the checkpoint 
results in cell death, probably due to mitotic catastrophe (Melixetian et al, 2004; Zhu et 
FIGURE 3. Strategy to impede origin relicensing. A. During G1 phase, initiator proteins are active 
and license replication origins. At S phase, origin firing signals, especially CDK activity, inhibit 
initiator proteins. This mechanism ensures that after a replication origin is fired, it cannot be activated 
again until the next cell cycle. Regulation of origin licensing and firing restricts replication to once per 
cell cycle. B. CDK oscillations and APC activity configure a “window of opportunity” for origin 
licensing. 
 
A 
B 
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al, 2004; Zhu and Dutta, 2006; Lin and Dutta 2007; Liu et al 2007). Re-replicated cells 
could activate the apoptotic program from G2 when p53 is functional (Vaziri et al, 
2003). BRCA1 and several components of the Fanconi Anemia (FA) pathway are 
necessary to activate the checkpoint in response to re-replication (Zhu and Dutta, 2006). 
In yeast, the checkpoint response is rad9-dependent and mrc1-independent, suggesting 
that DSBs rather than ssDNA exposure is the main signal that activates the pathway 
(Archambault et al, 2002; Green and Li, 2005). In contrast, in mammalian cells, ATR 
and CHK1 are activated before ATM and CHK2 in response to RS (Liu et al 2007; 
Neelsen et al 2013). In fact, depletion of the ATM branch had no effect over re-
replication-induced G2 arrest (Lin et al, 2006). These results indicate that ATR pathway 
is the main signal to activate the cellular response to DNA re-replication in mammals 
(Fig 4). 
 
 
 
Whether ATR activation is simply the consequence of DNA damage or the ATR 
pathway regulates the extension of re-replication and its eventual repair is a matter of 
debate. On one hand, when origin licensing is disrupted by overexpression of CDT1, 
ATR prevents re-replication extension in some cell lines (Liu et al 2007). On the other 
hand, blocking cells in G2 may facilitate the reactivation of replication origins, giving 
rise to higher levels of re-replication (Klotz-Noack et al 2012). In a situation of 
developmentally-controlled re-replication such as that occurring in Drosophila ovarian 
FIGURE 4. Cellular 
responses to re-replication. 
Re-replication promotes 
ssDNA accumulation and 
DSBs that activate ATR, FA 
and ATM pathways. 
Checkpoint activation 
promotes G2 arrest and 
eventually, cell death. ATR 
activation might also restrict 
re-replication. 
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follicle cells, checkpoint activation is required to allow the progression of re-replicated 
forks (Alexander et al, 2015). 
 
Two models have been proposed to explain how re-replication induces DNA DSBs. The 
first model was proposed in Xenopus egg extracts and it implies head-to-tail collisions 
between the two consecutive forks established from the same origin (Davidson et al, 
2006) (Fig 5). The model explains the presence of DNA fragments after several rounds 
of re-replication (Davidson et al, 2006) but it implies that re-replicated forks progress at 
a faster pace than regular forks, which needs to be formally demonstrated. The second 
model suggests that in conditions of deregulated origin licensing, the first round of 
replication leaves small sections of ssDNA that are converted in DSBs at the passage of 
the second fork on the same template (Fig 5). This model is supported by electron 
microscopy analyses of re-replicated forks (Neelsen et al, 2013). How re-replication 
promotes the accumulation of ssDNA gaps remains to be characterized. These models 
are not mutually exclusive. In addition, it has been proposed that DSBs could arise 
when re-replicated tracks copy through immature Okazaki fragments (Zhu and Dutta, 
2006b; Liu et al, 2007) but this possibility has not been experimentally addressed. 
 
 
 
FIGURE 5. Models to explain 
re-replication-induced DSBs.  
Left branch: If re-replicated 
forks progress faster than regular 
ones, they eventually collide. 
Head-to-tail fork collisions results 
in DSBs.  
Right branch: Deregulation of 
origin licensing induces 
accumulation of ssDNA in the 
first round of replication. When 
re-replicated tracks progress 
through these ssDNA gaps, forks 
collapse into DSBs. 
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In yeast, origin reactivation can lead to re-replication-induced gene amplification by 
non-allelic homologous recombination (NAHR; Green et al, 2010; Finn and Li, 2013). 
In this system, re-replicated forks are prone to break, and any partial homology between 
the two ends may be sufficient to induce recombination via single strand annealing 
(SSA; Finn and Li, 2013). This could be a specific feature of yeast, as only a fraction of 
the genome is re-replicated upon licensing deregulation (Tanny et al, 2006). Recently, 
sequences called re-initiation promoters have been identified that dictate which origins 
could be relicensed and which could not (Richardson and Li; 2014). The presence of re-
replication-prone origins in yeast could contribute to re-replication-induced gene 
amplification. In addition, re-replication of centromeres in budding yeast induces 
chromosome segregation problems and causes aneuploidy (Hanlon and Li, 2014). 
 
In mammalian cells, DNA re-replication appears to be spread throughout the genome 
(Klotz-Noack et al, 2012) and it could also drive chromosomal rearrangements and 
genomic instability, as observed upon CDT1 deregulation (Lovejoy et al 2006; Liontos 
et al, 2007). Cells derived from CDT1-transgenic p53-null mice show aneuploidy (Seo 
et al, 2005). A closer relationship between re-replication and genomic instability has 
been established recently in a subset of p53-null tumours with high p21 expression. 
These cells accumulate pre-RC proteins and display DNA re-replication and genomic 
instability (Galanos et al, 2016). Mitotic conflicts derived from re-replication could 
underlie the increase in genomic instability. 
 
Mechanisms that control re-replication 
In yeast, CDK activity is the main regulator of origin licensing (Fig 3). Phosphorylation 
of Cdc6, Orc2 and Orc6 inhibits their licensing activity. After the G1-S transition, CDK 
activity also promotes Cdc6 destruction and the translocation of Cdt1-MCM2-7 
complexes to the cytoplasm (reviewed in Arias and Walter, 2007). These mechanisms 
prevent origin re-licensing. 
 
In higher eukaryotes, CDK activity regulates ORC1 chromatin binding (Li et al 2004), 
as well as CDC6 nuclear-cytosolic translocation (Saha et al 1998; Petersen et al 1999; 
Jiang et al, 1999). This regulation appears to be restricted to soluble CDC6 
(Alexandrow and Hamlin, 2004) because a fraction of CDC6 remains bound to 
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chromatin during S, G2 and M phases (Mendez and Stillman, 2000). CDKs also 
phosphorylate CDT1 to promote its degradation via SCFSkp2 after G1 (Liu et al 2004).  
 
In addition, other mechanisms control the stability of preRC components throughout the 
cell cycle. A fraction of ORC1 subunit is degraded after S phase through SCFSkp2 
(Mendez et al, 2002), while other fraction remains on chromatin during the entire cell 
cycle (Okuno et al, 2001). Despite this regulation, individual ORC1 overexpression 
does not induce re-replication in human cells (Sugimoto et al, 2009).  
 
CDC6 is targeted for proteolysis by at least three E3 ubiquitin ligases: APC/CCdh1 at the 
exit from mitosis (Petersen et al 2000), CRL4-Cdt2 during S phase (Clijsters et al, 
2014), and SCFCyclin F from S phase to mitosis (Walter et al, 2016; Fig 6). APC/C-
dependent destruction is important to limit CDC6 levels in quiescent cells. 
Phosphorylation of CDC6 by Cdk2-Cyclin E stabilizes the protein to allow origin 
licensing during cell cycle re-entry (Mailand and Diffley, 2005). CDC6 overexpression 
induces limited re-replication in tumoral cells (Vaziri et al 2003; Liontos et al, 2007), 
but elimination of SCFCyclin F-dependent CDC6 regulation only results in re-replication 
when CDT1 activity is also deregulated (Walter et al, 2016).  
 
CDT1 stability is also controlled by three ubiquitin ligases: APC/CCdh1 at mitotic exit 
(Sugimoto et al, 2008), Cul4-Ddb1-Cdt2 in S phase and SCFSkp2 from S phase to mitosis 
(Nishitani et al, 2006; Fig 6). Cul4-Ddb1-Cdt2 regulation is restricted to S phase 
because it relies on CDT1 binding to PCNA (Arias and Walter, 2006; Senga et al, 2006) 
while SCFSkp2 could act during G2 and mitosis because it relies on phosphorylation of 
CDT1 Cy motif by CDK activity (Liu et al, 2004). Deregulation of CDT1 has a major 
impact on DNA replication, at least in tumoral cell lines. CDT1 overexpression is 
sufficient to promote extensive re-replication (Vaziri et al, 2003; Liontos et al, 2007; 
Teer and Dutta, 2008). Expression of mutant versions of CDT1 that impair the 
interactions with Cdh1, PCNA or Skp2 also induces re-replication to different extents 
(Sugimoto et al, 2008; Arias and Walter, 2006; Takeda et al, 2005). In addition, cell 
lines resistant to CDT1 overexpression are sensitized when ATR is interfered (Liu et al 
2007). Intriguingly, in non-cancerous cell lines CDT1 overexpression does not boost 
extensive origin refiring (Sugimoto et al, 2009).  
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Several pre-RC components, including CDC6 and CDT1, are degraded in the presence 
of DNA damage (Mendez et al, 2002; Hu et al, 2004; Duursma and Agami, 2005; Higa 
et al, 2006; Senga et al, 2006; Hall et al, 2007), probably to prevent origin relicensing 
when the DNA damage checkpoint inhibits CDK activity to block cell cycle progression 
(Arias and Walter, 2007; Hall et al, 2008).  
 
 
CDT1 protein is also regulated by the binding of a small inhibitor called Geminin 
(GMN), which prevents CDT1 activity between S and M (Fig 6; Wohlschlegel et al, 
2000). Hence, GMN depletion causes DNA re-replication in many cancer cell lines 
(Melixetian et al, 2004; Klotz-Noack et al, 2012) but not in primary cell lines (Zhu and 
DePamphilis, 2009).  Interestingly, GMN also facilitates origin licensing in G1 by 
protecting a fraction of CDT1 from degradation during G2 and M phases (Ballabeni et 
al, 2004). Finally, epigenetic modifications may also participate in re-replication 
control, as histone methyltransferases PRset7 and DOT1L are necessary to impede 
origin reactivation (Tardat et al, 2010; Fu et al 2013). 
 
Animal models for the study of DNA re-replication 
Most of the available information about the control of DNA re-replication has been 
derived from cultured cell lines. In invertebrates, it has been shown that DNA over-
replication has lethal consequences during embryonic development in C. elegans and D. 
melanogaster (Zhong et al, 2003; Thomer et al, 2004). Regarding mammalian 
organisms, no mouse models have been described in which the consequences of DNA 
over-replication could be studied in vivo. It is worth noting that several mouse models 
have been developed to investigate the opposite situation, i.e. insufficient origin 
licensing and activity. Mouse strains with partial MCM deficiency undergo genomic 
instability, haematopoietic defects and are prone to cancer (e.g. Shima et al, 2007; Pruitt 
FIGURE 6. Regulation of re-replication through GMN and ubiquitin ligases. GMN binds and 
inhibit CDT1 from S phase to late mitosis. Ubiquitin ligases target preRC proteins for degradation in 
different phases of cell cycle. APC complex (blue) is active from late mitosis to G1. CRL complexes 
(red) are active during S phase whereas SCF complexes perform their activity from S phase to the end 
of G2. See text for details. 
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et al, 2007; Kawabata et al, 2010; Alvarez et al, 2015). The potential oncogenic role of 
deregulated CDC6 and CDT1 has been individually addressed in mice (Búa et al, 2016; 
Seo et al, 2005), but no evidence of DNA re-replication was reported in these studies. 
Given the link between DNA re-replication and genomic instability, one of the 
objectives of this thesis has been the characterization of mouse models in which DNA 
re-replication could be induced in a controlled manner. 
 
Prevalence of origin re-firing and extension of re-replicated DNA 
In principle, re-replication is an aberrant process that should only be observed when the 
origin licensing process is deregulated. However, several evidences suggest that this 
process might be more prevalent than expected and that re-replication might also occur 
under physiological conditions (Green et al, 2006). A single ORC-Cdc6-Cdt1 complex 
can load multiple MCM complexes (Edwards et al, 2002; Bowers et al, 2004; Powell et 
al, 2015). When multiple MCM complexes are gathered around a single origin, there is 
a risk of re-activation in S phase. In human cells, it has been proposed that origins 
undergo several rounds of activation in S phase giving rise to small re-replicated DNA 
fragments, approximately 200 bp long (Gómez and Antequera, 2008). Up to 2.5% of 
ongoing forks detected in DNA fiber assays seem to arise from reactivated origins in 
control human cells, and their average extension is approximately 18 kb (Dorn et al, 
2009). In addition, it has been reported that more than 5% of control G2 cells 
incorporate EdU (Walter et al, 2016). 
 
The extension of re-replicated forks poses intriguing questions. For unknown reasons, 
re-replicated forks display less processivity and are prone to break (Green et al, 2006; 
Tanny et al, 2006; Finn and Li 2013). In yeast, regular forks are in charge of copying 
100-200 kb of DNA (Dershowitz and Newlon, 1993; van Brabant et al, 2001), while re-
replicated forks rarely travel longer than 30-35 kb from the origin (Nguyen et al, 2001).  
Comparative genomic hybridization (CGH) analysis in yeast shows no signs of re-
replication 100-200 kb away from origins (Green et al, 2006).  
 
These antecedents suggest that specific mechanisms may restrict the extension of re-
replicated DNA after origin re-firing events caused by faulty licensing control. Part of 
this Doctoral thesis explores the relationship between DNA re-replication and several 
mechanisms that operate when the normal DNA replication process is perturbed. The 
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following Introduction sections are dedicated to fundamental aspects of RS and its 
crosstalk with origin activity. 
  
Replication Stress 
RS is defined as the slowing or stalling of replication forks during DNA synthesis 
(Zeeman and Cimprich, 2014). An immediate consequence of fork stalling is the 
exposure of stretches of ssDNA that are rapidly covered by RPA. The amount of RPA 
bound to ssDNA influences the strength of the cellular responses to RS (MacDougall et 
al, 2007). Not all interferences with DNA replication activate a RS response (Huang et 
al 2010) and we have recently suggested to extend the definition of RS to indicate that 
the extent and duration of fork slowing/stalling ought to be strong enough to activate a 
specific checkpoint response (Muñoz and Mendez, 2016). In the absence of an 
appropriate response, the replisome at the stalled fork is eventually dismantled and the 
failed replicative structure collapses into a DSB.  
 
The possible causes and consequences of RS have been extensively discussed in recent 
reviews (Zeeman and Cimprich, 2014; Gaillard et al, 2015; Muñoz and Mendez, 2016). 
They include endogenous DNA damage as well as replication through DNA secondary 
structures, regions with DNA-bound non-histone proteins, fragile sites, centromeres, 
telomeres, topological conflicts and collisions with the transcriptional machinery. 
Exogenous genotoxic agents that induce DNA damage and/or affect the dNTP pool may 
also induce RS. 
 
ATR (ataxia-telangiectasia mutated and RAD3-related) kinase is the main regulator of 
the cellular response to RS. It is activated by RPA-covered ssDNA (Cimprich and 
Cortez 2008) and phosphorylates multiple proteins, including the effector Chk1 kinase 
(Matsuoka et al. 2007). This pathway activates three responses: stabilization of stalled 
forks, inhibition of late origin firing, and inhibition of mitotic entry. Combined, these 
responses provide time to deal with the source of RS before the restart of DNA 
replication. 
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RS and origin activity 
Dormant origins and the checkpoint response: “inhibit globally, activate locally” 
When a stalled fork is unable to restart DNA synthesis, replication is normally 
“rescued” from a fork moving in the opposite direction (derived from an adjacent 
origin). The situation is more complicated when two forks moving towards each other 
are simultaneously stalled. Since the assembly of new replicative helicases on DNA is 
prevented during S phase, replication between the two stalled forks could be left 
incomplete and generate aberrant DNA intermediaries and anaphase bridges in mitosis, 
which in turn become chromosomal breaks (Liu et al, 2014). This problem is minimized 
by the licensing of multiple “dormant origins” in G1 (reviewed by Alver et al, 2014), 
which serve as a backup mechanism to reinitiate replication in response to stalled forks 
(Fig 7). Indeed, elimination of dormant origins by MCM downregulation sensitizes cells 
to drugs that challenge fork progression (Ge et al, 2007; Ibarra et al, 2008). In fact, 
Mcm4 hypomorphic cells display genomic instability even in the absence of exogenous 
replication challenges (Kawabata et al, 2010). Consistently, the lack of dormant origins 
in mouse models hypomorphic for different MCM subunits makes them cancer-prone 
(Pruitt et al, 2007; Shima et al, 2007; Bagley et al, 2012; Alvarez et al, 2015). 
 
Cells must coordinate two different actions on replication origins in response to RS. On 
one hand, the checkpoint response should block late replication (i.e. late origins) until 
cells recover from RS. On the other hand, dormant origins should be activated to 
complete replication and maintain genome stability. As a solution to this paradox, it has 
been proposed that checkpoint proteins inhibit origin firing globally, while locally 
promoting backup origin activation around stalled forks (Fig 7; Ge and Blow, 2010; 
Yekerazee et al, 2013). The arrangement of groups of adjacent origins in replication 
factories (Jackson and Pombo 1998; Guillou et al, 2010; Aparicio et al, 2012) likely 
contributes to separate local and global effects.  
 
At the mechanistic level, the ATR-CHK1 axis may inhibit global origin activity by 
targeting Sld3/Treslin and the Dbf4 subunit of the DDK kinase (Fig 7; Costanzo et al, 
2003; Syljuasen et al. 2005; Maya-Mendoza et al, 2007; Lopez-Mosqueda et al, 2010; 
Zegerman and Diffley 2010; Guo et al, 2015). In contrast, how dormant origins are 
activated locally is still a matter of investigation. It has been proposed that following 
MCM2 phosphorylation by ATR at stalled forks, Polo kinase (PLK1) promotes CDC45 
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loading at nearby dormant origins, leading to their activation (Trenz et al, 2008). 
Moreover, PLK1 modulates claspin levels (Mainland et al 2006; Peschiaroli et al 2006), 
which may restrict CHK1 activity nearby stalled forks. FANCI protein, a member of the 
FA DNA repair pathway, has been recently related to dormant origin activation, 
although the precise mechanism remains unclear (Chen et al, 2015). 
 
 
RS and aberrant origin firing 
Deregulated origin activity is also a cause of RS. Origin over-usage leads to an 
accumulation of active forks that might reduce the pool of dNTPs or other limiting 
replisome components such as RPA (Bester et al, 2011; Toledo et al, 2013). In addition, 
it increases the chance of collisions with the transcription machinery (Jones et al, 2013). 
Notably, oncogene activation unbalances the licensing process (Eckholm-Reed et al, 
2004) and has a direct effect in origin firing. It has been proposed that the DNA damage 
and senescence response induced by oncogenes are the result of aberrant origin activity 
at early stages of cancer development (Halazonetis et al, 2008; Hills and Diffley, 2014). 
 
 
 
FIGURE 7. Dormant origin activation. Upon RS, dormant origins can be activated to rescue 
replication. The ATR and CHK1 pathway plays a dual role in this process. Inhibition of CDKs impedes 
activation of late replication origins through Dbf4 and Treslin. However, near the stalled forks, they 
promote dormant origin firing through FANCI and PLK1 activity. See text for details. 
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DNA replication restart at stalled forks 
Fork stability, remodelling and restart 
The replisome proteins and the structure of the fork itself must be stabilized in response 
to RS. Early studies postulated that the yeast orthologues of ATR and CHK1 (Mec1 and 
Rad53) were needed to maintain a stable replisome at stalled forks (Lopes et al 2001; 
Tercero and Diffley 2001; Cobb et al, 2003; Katou et al, 2003). However, more recent 
studies showed that replisomes are stably maintained at stalled forks in the absence of 
Mec1 and Rad53. Checkpoint phosphorylation of replisome components might be 
related to the control of replisome function rather than its stability (DePiccoli et al 
2012). 
 
Checkpoint activity could regulate fork remodelling into four-way junctions through a 
process called fork reversal (Fig 8). Reversed forks were initially described in 
checkpoint-deficient yeast strains subjected to RS and were considered an aberrant 
structure that would lead to fork breakdown and genome instability (Lopes et al 2001; 
Sogo et al; 2002). Nevertheless, recent data from human cells suggests that fork reversal 
is a transient physiological response that stabilizes the fork before DNA replication is 
resumed (reviewed by Neelsen and Lopes, 2015).  
 
 
The process of fork reversal is mediated by different proteins, including FBH1 and 
SMARCAL1 helicases (Couch et al, 2013; Fugger et al, 2015) and Poly(ADP-ribose) 
polymerase (Ray Chaudhuri et al, 2012). Importantly, fork reversal is strictly dependent 
on RAD51 recombinase (Zellweger et al, 2015). Other helicases including BLM, WRN, 
RECQ5, RAD54, ZRANB3, HLTF or FANCM can reverse forks in vitro (reviewed by 
FIGURE 8. Proteins that mediate fork reversal. Proteins that perform this reaction in vivo are 
depicted in black. Proteins with fork remodelling activity in vitro that can promote fork restart in vivo 
are shown in red. In red brackets, proteins that catalyse fork reversal in vitro. RECQ1 and WRN-DNA2 
mediate two independent mechanisms to remodel reversed structures into normal forks. 
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Neelsen and Lopes, 2015). Amongst them, at least BLM, WRN, ZRANB3 and FANCM 
have been involved in fork restart (Davies et al, 2007; Ciccia et al, 2012; Yuan et al, 
2012; Schwab et al, 2010; Sidorova et al, 2008).  
 
Resumption of DNA synthesis from a regressed fork needs a second remodelling event 
that in vivo involves WRN. The mechanism is not completely understood but the 
ATPase activity of WRN, together with DNA2-mediated degradation of regressed arms, 
facilitates fork restoration (Thangavel et al, 2015). DNA2 activity is limited by BOD1L 
protein to avoid DNA over-resection (Higgs et al, 2015). A second mechanism to 
restore normal forks from regressed ones in vivo is catalyzed by RECQ1 helicase (Berti 
et al, 2013). 
 
 
Reversed forks also contribute to checkpoint activation because they resemble DSBs 
(Fugger et al 2015) and are therefore sensitive to nucleolytic degradation (Fig 9). 
Indeed, MRE11-dependent resection of DNA at stalled forks has been associated with 
genomic instability (Schlacher et al, 2011, 2012). FA proteins and BRCA2 promote 
RAD51 binding to stalled forks to counteract this degradation (Hashimoto et al, 2010; 
Schlacher et al, 2011, 2012; Fig 9). Other proteins involved in fork protection from 
MRE11 degradation are PARP1 (Ying et al, 2012), RAD51 paralogs (Somyajit et al, 
2015), WRN (Su et al, 2014) and WRNIP1 (Leuzzi et al, 2016). In addition, ATR 
FIGURE 9. Fork stability after stalling. Stalled and reversed forks are susceptible to nuclease 
degradation. BRCA2 and FA proteins load RAD51 in these structures to protect them. ATR and 
BOD1L also contribute to fork stability by limiting EXO1 and DNA2 activities. FBH1, BLM, RECQ5 
and other antirecombinases limit unscheduled HR. 
 
 32 
activity prevents fork degradation by inhibiting EXO1 or CtIP exonucleases (El-
Shemerly et al, 2008; Couch et al, 2013; Fig 9).  
Although fork reversal might be part of RS response, reversed forks are recombinogenic 
structures (Cotta-Ramusino et al, 2005). Therefore, the homologous recombination 
(HR) pathway must be regulated to avoid negative consequences (Fig 9; Carr and 
Lambert, 2013). Control of RAD51 activity is a key step in this regard. RAD51 
participates in both fork restart and recombination-mediated repair (Petermann et al, 
2010). After short HU treatments, HR is inhibited and RAD51 may be involved in fork 
protection and DNA damage tolerance mechanisms. However, long HU treatment 
induces fork collapse and RAD51-mediated HR repair. 
 
Several pathways may be involved in limiting HR in the RS response through RAD51 
regulation (Fig 9). FBH1 displaces RAD51 filaments from ssDNA (Simandlova et al, 
2013) and monoubiquitylates RAD51 to export it from the nuclei in response to HU 
(Chu et al, 2015). Other helicases such as BLM, RECQ5, FANCJ and RAD54 also 
displace RAD51 from DNA (Wu et al, 2001; Bugreev et al, 2007; Hu et al, 2007; 
Sommers et al, 2009; Shah et al, 2010), whereas RECQ1 and FANCM restrict HR by 
dissociating displacement loops  (D-loops) (Bugreev et al, 2008; Rosado et al 2009).  
 
Other mechanism to resume DNA replication 
Eukaryotic cells have developed other mechanisms to complete replication in stress 
situations (Fig 10), which are not the focus of this doctoral thesis but are briefly 
described below.  
 
DNA damage tolerance (DTT) mechanisms allow skipping DNA lesions during DNA 
replication. These lesions are then repaired post-replicatively, when two sister 
chromatids are available. There are two branches of DTT, translesion synthesis (TLS) 
and template switching (TS). The choice between them relies in the status of PCNA 
ubiquitylation (reviewed in Sale et al. 2012; Mailand et al, 2013). TLS is carried out by 
specialized DNA polymerases whose flexible active sites allow the insertion of 
nucleotides opposite damaged templates (reviewed by Lange et al, 2011; Sale et al. 
2012; Fig 10A). TS is a recombination-related mechanism in which the stalled nascent 
DNA strand invades the sister chromatid to continue replication using undamaged 
newly synthesized strand as template (reviewed by Branzei, 2011; Fig 10B). 
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Stalled forks that could not be restarted are processed by structure-specific 
endonucleases such as Mus81-Eme1 (Hanada et al. 2006) that induce DSBs. These 
collapsed forks are repaired by HR. In the standard HR reaction at a DSB, the MRE11-
RAD50-NBS1 (MRN) complex is recruited to the break and MRE11 performs DNA 
end resection. Then RAD52 and BRCA2 target RAD51 onto ssDNA and the RAD51-
ssDNA filament invades the sister chromatid to generate a D-loop where DNA 
synthesis occurs. Other factors as RAD51AP1 or RAD54 support strand invasion and 
D-loop formation or dissociation. The final step may be carried out by different HR 
subpathways: synthesis-dependent strand annealing (SDSA), generation and resolution 
of double Holliday junctions, and break-induced replication (BIR; reviewed by Heller et 
al, 2010; Daley et al, 2013). 
 
 
 
Collapsed forks generate one-ended DSBs that are repaired by BIR (Costantino et al, 
2014; Fig 10D). In yeast, Pif1 helicase cooperates with the HR machinery and 
replisome components to establish the migrating D-loop (Lydeard et al 2010; Wilson et 
al 2013). Replication proceeds for hundreds of kilobases (Davis and Symington 2004) 
via migrating bubble-like replication fork resulting in uncoupling leading and lagging 
FIGURE 10. Mechanisms to 
resume DNA replication at stalled 
forks. A. TLS is performed by 
specialized polymerases that are 
able to synthesize DNA through 
damaged templates. B. TS is a 
recombination-related mechanism to 
bypass damaged templates. C. 
PrimPol promotes continuous DNA 
synthesis by repriming ahead of 
DNA lesions. D. Structure-specific 
endonucleases perform DSBs on 
stalled forks unable to restart. 
Collapsed forks are repaired through 
BIR. After resection, RAD51 
catalyses strand invasion. 
Replication proceeds over hundreds 
of kilobases on the sister chromatid 
in a migrating bubble-like 
replication fork,. 
 
A 
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strands synthesis, ssDNA accumulation and a conservative inheritance of DNA (Saini et 
al 2013; Wilson et al 2013).  
 
Whether any of the described mechanisms that remodel or repair stalled forks are also 
involved in the processing of re-replicated forks is one of the questions addressed in this 
doctoral thesis.  
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OBJECTIVES 
 
 
1. Study the effects of Cdc6 and Cdt1 deregulated expression in primary 
mouse embryonic fibroblasts: changes in cell cycle progression, dynamics of 
DNA replication and generation of DNA damage. 
 
2. Study the consequences of Cdc6 and Cdt1 deregulated expression during 
embryonic development and in adult mice, elucidating whether it leads to 
DNA re-replication in vivo.  
 
3. Identification of cellular mechanisms that prevent DNA re-replication 
associated to origin reactivation.  
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MATERIALS AND METHODS  
 
Mice procedures 
 
Ethical statement 
Mice were kept in the Animal Facility at CNIO in accordance with institutional policies 
and the ‘Federation for Laboratory Animal Science Associations’ (FELASA) 
guidelines. Animal procedures were approved by the Animal Experimental Ethics 
Committee of the Instituto de Salud Carlos III (Madrid, Spain). 
 
Mice genotyping 
Genotyping was performed by PCR analysis of genomic DNA isolated from tail clips 
following a standard protocol (Malumbres et al., 1997). Tails were lysed in PCR-K 
buffer (50 mM KCl, 1.5 mM MgCl2, 10 mM Tris-HCl pH 8.5, 0.01% gelatin, 0.45% 
NP-40, 0.45% Tween-20, 100 μg/mL proteinase K (Roche)) for 2 h at 55°C in agitation. 
Proteinase K was inactivated at 95°C for 15 min. PCR reactions were performed as 
follows:  2 μL of genomic DNA, 0.2 μL of Taq polymerase (Ecogen), 2.5 μL of 10X 
Taq reaction buffer (Ecogen), 1.5 μL of 50 mM MgCl2 (Ecogen), 1 μL of each primer 
from a 10 μM dilution in H20, 1 μL of 10 mM dNTPs (Fermentas), and H2O to a final 
volume of 25 μL. The different primers used for mice genotyping are listed in Table 1. 
 
Isolation of intestinal epithelium, bone marrow and fetal liver cells 
The crypt-enriched fraction of intestinal cells was obtained following a described 
procedure (Sato and Clevers, 2013). E13.5 fetal livers or adult femur bone marrow 
(BM) were disaggregated in 2% FBS-RPMI by multiple passages through a 26G needle 
and filtered through a 70 μm strainer (BD Falcon). Fetal liver and BM cells were pulse-
labelled ex-vivo with 10 M BrdU for 30 min at 370 C. Afterwards cells were processed 
for flow cytometry analysis. A fragment of tissue was taken for subsequent genotyping. 
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RNA expression analysis 
 
RNA isolation, retrotranscription and quantitative PCR (RT-qPCR) 
Tissues or cell cultures were disrupted and homogenized in Trizol (Invitrogen) using a 
bead-beating system (Precellys). Total RNA was isolated according to manufacturer’s 
instructions. Potential genomic DNA contamination was removed by DNaseI digestion 
(Roche). cDNA was obtained with Maxima First Strand cDNA kit (Thermo) according 
to the manufacturer’s instructions. 1/100 cDNAs dilutions were used. qPCR was 
performed in triplicates using SYBR green-Real Time PCR master mix (Applied 
Biosystems). qPCR analyses were done in an Applied Biosystems 7900HT Fast Real 
Time PCR System equipment and analyzed with 7900HT Sequence Detection System 
(Applied Biosystems). Primers used for RT-qPCR analyses are shown in Table 2. 
Amplified fragments were quantified by 2ΔΔCt method. Expression levels were 
normalized to GAPDH housekeeping gene.  
 
Cell culture procedures 
 
Primary Mouse Embryonic Fibroblasts (MEFs) isolation and culture 
Mouse embryos were obtained at E12.5-14.5 days. Pregnant females were sacrificed by 
cervical dislocation and uterine horns were removed and transferred to a sterile PBS 
solution. In a laminar flow hood, embryos were removed from the uterus, fetal liver was 
excised and a fragment of tissue was taken for subsequent genotyping. The rest of 
embryonic tissue was minced and treated with 0.25% trypsin-EDTA (Sigma-Aldrich) 
for 20 min at 37°C. Cells were further disaggregated by pipetting, transferred to 9 mL 
medium (DMEM complete (Lonza), 20% FBS (Sigma-Aldrich), 10% 
penicillin/streptomycin solution (Invitrogen)), seeded in tissue culture plates and grown 
at 37°C and 5% CO2. Cells were expanded and frozen at passage 1 in 90% FBS, 10% 
dimethyl sulfoxide (DMSO, Sigma-Aldrich). Upon thawing, MEFs were cultured with 
medium supplemented with 10% FBS. All experiments with primary MEFs were 
performed at low passage number (≤ 4).  
 
Generation of HCT116-shGMN cells 
Stable HCT116-shGMN cell lines were obtained using a TRIPZ lentiviral vector 
carrying an inducible shRNA targeting the sequence 5’-TATGTAGTTATGTACTCTG-
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3’ in the 3’ untranslated region (UTR) of GMN gene (GE Healthcare, USA). 
Lentiviruses were produced in 293T cells. HCT116 cells were infected twice and 
selected with 5μg/ml puromycin for 5 days. Resistant colonies were pooled and 
maintained in DMEM (Lonza) + 10% FBS (Sigma-Aldrich) + 10% 
penicillin/streptomycin solution (Invitrogen) + 0.5 μg/ml puromycin. Expression of 
GMN shRNA was induced with 2 μg/ml doxycyclin (Dox) for 3 days. 
 
Genetic screening for factors modulating DNA re-replication 
HCT-116 shGMN cells were cultured in μCLEAR bottom polylysine-treated 96-wells 
(Greiner Bio-One) in technical triplicates using medium supplemented with 2 μg/ml 
dox. Two controls (-dox and +dox) were seeded in every plate for normalization. 24 h 
after seeding. cells were transfected with individual esiRNA molecules (30 nM) from 
the designed esiRNA library (Sigma-Aldrich). Specific siRNAs against Luciferase 
(ctrl), Fbh1, Rad54 and Slx4 genes were added to the library. 72 h after seeding, cells 
were washed with PBS and fixed with PBS + 2% PFA for 10 min at RT. Cells were 
stained with 1 μg/ml DAPI (Sigma) in PBS for 3 min. Plates were analyzed in an Opera 
High-Content Screening System (PerkinElmer, USA) with an APO 20x, 0.7 NA water-
immersion objective. Nuclei were segmented and area was evaluated with Acapella 
software 2.6 version (PerkinElmer, USA). >500 cells were quantified in each well. The 
median nuclear size in each well was quantified. Mean of control (-dox) medians was 
calculated and each well was normalized to this value.  
 
siRNA and plasmid transfections 
Transfections were carried out using Lipofectamine 2000 (Invitrogen) following 
manufacturer’s instructions. A single transfection was used for plasmids, and two 
transfectios for siRNA molecules (50 nM). A list of the siRNAs used can be found in 
Table 3. 
 
Proliferation curves 
Aliquots of 50,000 MEFs were seeded in 6-well plates in duplicates, harvested at the 
indicated time points and counted in a Neubauer hemocytometer. 
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Serum starvation and cell cycle re-entry 
Cells were cultured to near 100% confluence in DMEN supplemented with 10% FBS. 
Then, to induce a G0 quiescent state, cells were serum starved cultured them in DMEN 
+ 0.1% FBS for 72 hours. For cell cycle re-entry, cells were split and seeded at 50% 
confluence with DMEN supplemented with 20% FBS. At indicated time points, cells 
were pulse-labelled with 10μM BrdU pulse labelling for 30 min and harvested for 
ulterior analysis. 
 
Cell cycle synchronization with thymidine 
HCT116 cells were incubated in medium supplemented with 2.5 mM thymidine for 20 
h to induce a G1/S block. Cells were washed and released in fresh medium for 7 h to 
obtain a population enriched in S+G2+M phases. 
 
Preparation of whole cell extracts 
Cells were trypsinized, collected by centrifugation (290 g/5 min), counted in a 
Neubauer hemocytometer, washed with PBS, lysed in Laemmli Sample Buffer (50 mM 
Tris-HCl pH 6.8, 10% glycerol, 3% SDS, 0.006% w/v bromophenol blue and 5% 2-
mercaptoethanol) at 5000 cells/μL and sonicated using two pulses at 20% amplitude for 
29 s (Branson Digital Sonifier). 
 
Biochemical fractionation 
Biochemical fractionations were performed as described (Méndez and Stillman, 2000). 
Briefly: Cells were resuspended at 2·107 cells/mL in buffer A (10 mM HEPES pH 7.9, 
10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 1 mM 
NaVO4, 0.5 mM NaF, 5 mM β- glycerophosphate, 0.1 mM PMSF), and incubated on 
ice for 5 min in the presence of 0.1% Triton X-100. Low- speed centrifugation (4 
min/600 g/4°C) allowed the separation of the cytosolic fraction (supernatant) and nuclei 
(pellet). Nuclei were washed and subjected to hypotonic lysis in buffer B (3 mM EDTA, 
0.2 mM EGTA, 1 mM DTT, 1 mM NaVO4, 0.5 mM NaF, 5 mM β- glycerophosphate, 
0.1 mM PMSF, protease inhibitors cocktail) 30 min on ice. Nucleoplasmic and 
chromatin fractions were separated after centrifugation (4 min/600 g/4°C). Chromatin 
was resuspended in Laemmli Sample Buffer and sonicated twice for 29 seconds at 20% 
amplitude. 
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Immunoprecipitation and immunoblots 
Cells were lysed in NP-40 buffer (150 mM NaCl, 1% NP-40, 50 mM Tris-HCl pH 8.0, 
0.1 mM PMSF, Roche protease inhibitors) at 4x106 cells/ml. Extracts were clarified by 
high-speed centrifugation (15 min/ 16000 g/ 4C) and cleared with protein A agarose 
beads (Santa Cruz, USA) for 30 min. IPs were performed overnight with 3 μg of the 
indicated antibody. Protein A agarose beads were added to extracts and incubated for 1 
h, collected by low-speed centrifugation (1 min/2500 g/4C), washed and resuspended 
in Laemmli buffer.  
 
SDS-polyacrylamide gels and immunoblotting were performed following standard 
protocols (Harlow and Lane, 2006). The primary antibodies used are listed in table 3. 
Horseradish peroxidase (HRP)-conjugated secondary antibodies (Amersham 
Biosciences) at 1:5000 dilution and ECL developing reagent (Amersham Biosciences) 
were used.  
 
BrdU incorporation and flow cytometry  
For BrdU incorporation and DNA content evaluation cells were pulse-labelled with 10 
μM BrdU (Sigma) for 30 min before harvesting. Cells were fixed in 70% ethanol, 
treated with 2M HCl for 20 min, washed and incubated with FITC- conjugated anti-
BrdU antibody (60 min/ 37C). To monitor DNA content, cells were stained overnight 
with 50 μg/ml propidium iodide (PI; Sigma) in PBS in the presence of 10 μg/ml RNase 
A (Qiagen). 
 
For γH2AX detection, MEFs were harvested and fixed with 4% PFA (15 min/ RT) and 
permeabilized with 0.5% Triton-X100 in PBS (10 min/ 4C). Cells were incubated in 
blocking solution (1% bovine serum albumin in PBS; 0.05% Tween-20) for 15 min. 
Primary and secondary antibodies were incubated in blocking solution for 1 h at RT. 
DNA was stained with 5 μg/ml Hoestch 33342(Invitrogen) in PBS + 0,05 Triton X-100. 
 
For apoptosis quantification, MEFs were harvested and incubated for 10 min at 37º C 
with 40 nM tetramethylrhodamine ethyl ester (TMRE, Sigma). Cells were then washed 
and resuspended in PBS. DAPI (Sigma) staining was used as viability dye. Flow 
cytometry was performed in a FACS Canto II cytometer (BD, San Jose, CA) and 
analyzed with FlowJo 9.4 (Tree Star, Ashland, OR). 
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For cell cycle phases sorting, MEFs were stained at 107 cells/ml with 5 μg/ml Hoestch 
33342 (Invitrogen) for 30 min at 37ºC in DMEN + 10% FBS. Cells were washed and 
resuspended at 106 cells/ml in DMEN + 0.1% FBS. Cells were sorted by DNA content 
in a BD Influx sorter (BD, San Jose, CA) by the Cytometry Unit at CNIO. 
 
Immunofluorescence 
Cells were cultured in polylysine-treated coverslips. At harvesting time cells were fixed 
in 4% PFA (15 min/ RT) and permeabilized with 0.5% Triton-X100 in PBS (5 min/ 
RT). Coverslips were incubated in blocking solution (3% BSA or 5% normal donkey 
serum (Jackson ImmunoResearch) in PBS + 0.05% Tween 20) for 30 min. Primary and 
secondary antibody (1:200 dilution) incubations were performed in blocking solution 
for 1 h at RT. Nuclei were stained with 1 μg/ml DAPI (Sigma) in PBS for 1 minute. 
ProLong Gold antifade reagent was used as mounting media for IF. To visualize 
chromatin-bound proteins (MCMs, RPA, 53BP1, RAD51), cells were subjected to a 
pre-extraction step with 0.5% Triton X-100 in CSK buffer (10 mM PIPES pH 7.0, 0.1 
M NaCl, 0.3 M sacarose and 3 mM MgCl2, 0.5 mM PMSF) prior to PFA fixation for 5 
min at 4°C. Click-it chemistry EdU detection kit (Invitrogen) was used when indicated. 
 
For AuroraB, pH3 and EdU stainings, images were acquired in a DM6000 B 
microscope (Leica microsystems, Germany). pH3- and EdU-double positive cells, G2 
cells and mitotic index were scored manually. For RPA, 53BP1 and RAD51 stainings, 
images were captured in a SP2 (AOBS) confocal microscope (Leica microsystems, 
Germany). Image analysis was performed in the Confocal Microscoy Unit at CNIO. 
Pre-designed routines for foci or nuclei detection in Definiens Developer XD v2.5 
software (Definiens, Germany) were used to evaluate either RPA or 53BP1 foci or 
RAD51 positive nuclei.  
 
For microscopic analysis of colon sections, tissues were stained with 1 μg/ml DAPI 
(SIGMA). Samples were acquired on a TCS- SP5 (AOBS) Confocal microscope (Leica 
microsystems, Germany) with a 20 X HCX PL APO 0.7 N.A. dry Objective. Nuclei 
from Colon cripts were segmented and integral intensity was quantified by using 
Definiens Developer XD v2.5 software (Definiens, Germany). 312 crypt cells from 4 
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different colon areas were measured from each animal. 3 animals from each condition 
were evaluated. 
 
When indicated, cells were cultured in μCLEAR bottom polylysine-treated 96-wells 
(Greiner Bio-One) in triplicates and analyzed in an Opera High-Content Screening 
System (PerkinElmer, USA) with an APO 20x, 0.7 NA water-immersion objective. 
Nuclei were detected with DAPI staining, and γH2AX or MCM intensities were 
measured within the nuclei mask using Acapella software (PerkinElmer, USA). For 
replication foci detection, HCT116 cells were pulse-labelled with 10 μM BrdU (Sigma) 
for 30 min previously to immunostaining. Foci detection routine was used to score 
BrdU foci number within each nucleus using the same software. 
 
ssDNA detection with native BrdU staining 
Cells were cultured in μCLEAR bottom polylysine-treated 24-wells (Greiner Bio-One) 
in triplicates. For nascent ssDNA (reversed forks) detection, cells were pulse-labeled 
with 10 μM BrdU (Sigma) for 10 min, washed, released in fresh medium and harvested 
at the indicated time points. For parental ssDNA detection, cells were pulse-labeled 
with 10 μM BrdU (Sigma) for 24 h, washed, released in fresh medium and harvested 24 
h later. Immunodetection was conducted as described (Couch et al, 2013) with slight 
modifications. Cells were pre-extracted in CSK buffer + 0.5% Triton X-100 for 5 min at 
4° C, fixed in 3% paraformaldehyde / 2% sucrose solution for 10 min at RT and 
blocked with 3% BSA in PBS + 0.05% Tween 20 15 min at RT. Cells were then 
incubated with mouse anti-BrdU antibody (BD Pharmingen; 1:50 dilution in blocking 
solution) for 60 min at 37 C followed by Alexa-488 goat anti-mouse (Invitrogen) 
secondary antibody (1:200 dilution in blocking solution) for 30 min at 37°C. Nuclei 
were stained with 1 μg/ml DAPI (Sigma). 
 
Images were captured in Opera High-Content Screening System (PerkinElmer, USA) 
with an APO 20x, 0.7 NA water-immersion objective. Nuclei were segmented and 
BrdU intensity was assessed with Acapella software (PerkinElmer, USA). 
 
Single-molecule analysis of DNA replication in stretched fibers 
Exponentially growing cells were pulse-labeled with 50 μM CldU (20 min) followed by 
250 μM IdU (20 min). Labeled cells were harvested and resuspended in cold PBS at 
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0.25·106 cells/mL. 500 cells were lysed in 0.2 M Tris pH 7.4, 50 mM EDTA, 0.5% SDS 
6 min at 30° C in a microscope slide into a humidity chamber. Slides were 15° tilted to 
stretch DNA fibers. DNA spreads were air-dried, fixed in cold 3:1 methanol: acetic acid 
for 2 min and refrigerated. Slides were treated with 2.5 N HCl for 30 min, washed 3 
times with PBS and blocked in 1% BSA, 0.1% Triton X-100 in PBS for 1 h before 
incubation. For immunodetection of labeled tracks, fibers were incubated with primary 
antibodies for 1 h at RT and the corresponding secondary antibodies for 30 min at RT, 
in a humidity chamber. ProLong Gold antifade reagent (Invitrogen) was used as 
mounting media for IF. DNA was visualized with an anti-ssDNA antibody to assess 
fiber integrity.  
 
To measure re-replicated tracks, cells were pulse-labeled with 50 μM CldU (120 min) 
followed by 250 μM IdU (30 min) as described (Neelsen et al, 2013). DNA fibers were 
incubated in stringency buffer (10 mM Tris-HCl pH 7.4; 0.4M NaCl; 0.2% Tween-20; 
0.2% NP-40) for 10 min between incubations with primary and secondary antibodies 
(Dorn et al, 2009). Fiber images were obtained in a DM6000 B Leica microscope with 
an HCX PL APO 40x, 0.75 NA objective.  
 
Fork progression rate was monitored in second-labeled (IdU) tracks. The length of 200-
300 tracks was measured per condition using ImageJ software. Inter-origin distances 
(IODs) were measured between two contiguous origins in the same fiber. The lengths of 
30-50 IODs were measured per condition. 500 total structures were measured to 
evaluate percentage of origin firing. 500 total green tracks were measured to evaluate 
percentage of re-replication. All re-replicated tracks found were measured to evaluate 
their length. The conversion factor used was 1 μm = 2.59 kb (Jackson and Pombo, 
1998). 
 
Histological analysis 
Formalin-fixed tissue processing for histological analysis was done in the 
Histopathology Unit at CNIO. Tissue samples were fixed in 10% neutral buffered 
formalin (4% formaldehyde in solution), paraffin-embedded and cut at 3 µm, mounted 
in superfrost®plus slides and dried overnight. For different staining methods slides 
were deparaffinized in xylene and and re-hydrated through a series of graded ethanol 
until water. Consecutive sections were stained with hematoxylin and eosin (H&E) and 
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for immunohistochemistry an automated immunostaining platform was used (Ventana 
Discovery XT, Roche ). Antigen retrieval was first performed with high or low pH 
buffer depending on the primary antibody (CC1m, Roche or RiboCC, Roche), 
endogenous peroxidase was blocked (peroxide hydrogen at 3%) and slides were then 
incubated with the appropriate primary antibody as detailed: rat monoclonal anti-p21 
(291H; 1:10; Monoclonal Antibodies CNIO), rat monoclonal anti-p16 (327C; 1:10; 
Monoclonal Antibodies CNIO), rabbit polyclonal anti-Sox9  (1:800; Millipore, 
AB5535), rabbit monoclonal Ki67 (1:500; SP6; Master Diagnostica 000311OQD), 
rabbit polyclonal anti-Phospho Histone H3 (1/500; Millipore 06-570), rabbit polyclonal 
anti-Cleaved caspase 3 (1:750; Cell Signaling 9661) and mouse monoclonal anti-
γH2AX (Millipore, 05-636; 1:100). After the primary antibody, slides were incubated 
with the corresponding secondary antibodies (rabbit anti rat, Vetor Labs) and 
visualization systems when needed (OmniRabbit, Ventana, Roche) conjugated with 
horseradish peroxidase. Immunohistochemical reaction was developed using using 
3,30-diaminobenzidine tetrahydrochloride (DAB) as a chromogen (Chromomap DAB, 
Ventana, Roche or DAB solution, Dako) and nuclei were counterstained with Carazzi’s 
hematoxylin. Finally, the slides were dehydrated, cleared and mounted with a 
permanent mounting medium for microscopic evaluation. Tissue slides were digitalized 
using a Mirax Scan or Axio Scan.Z1 scanners (Carl Zeiss, Germany) and images 
captured with the Zen Software (Zeiss). Image analysis and quantification was 
performed using AxioVision rel 4.6 digital image software (Carl Zeiss, Germany). 
Areas of positive staining were normalized to the total analyzed area. SOX9 positive 
nuclei were segmented after detection. CA3 and pH3 positive cells were scored 
manually.  
 
Genome-wide data analyses 
We analyzed available data in the NCBI Gene Expression Omnibus (GEO) database for 
ORC2 ChIP-Seq (GEO accession number GSE70165; Miotto et al, 2016) RAD51 ChIP-
Seq (GEO accession number GSE91838) and short-nascent-strand (SNS) data (GEO 
accession number GSE46189; Picard et al, 2014). Data was analyzed with “Intersect 
intervals” tool from BEdTools package (Quinlan and Hall, 2010) in Galaxy website. 
The following requirements were used in overlap analyses: minimum overlap of 10% , 
reciprocal and unique overlap (-u). 
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Tables 
 
Table 1. Primers for mice genotyping 
Primer Sequence Locus 
Col-A GCACAGCATTGCGGACATGC Col1A1 
Col-B CCCTCCATGTGTGACCAAGG Col1A1 
Col-C GCAGAAGCGCGGCCGTCTGG Col1A1 
ROSA-1 GCGAAGAGTTTGTCCTCAACC Rosa26 
ROSA-2 GGAGCGGGAGAAATGGATATG Rosa26 
ROSA-3 AAAGTCGCTCTGAGTTGTTAT Rosa26 
 
Table 2. Primers for qPCR 
Primer Sequence Gene 
CDC6-Fw ACACACTGTTTGAGTGGCCGT mCdc6 
CDC6-Rev GCTTCAAGTCTCGGCAGAATTC mCdc6 
CDT1‐Fw TAGTACCCCAGATGCCAAGG mCdt1 
CDT1‐Rev GTAGGACAAGGCCTGGGAGA mCdt1 
GAPDH-Fw TGAAGCAGGCATCTGAGGG GAPDH 
GAPDH‐Rev CGAAGGTGGAAGAGTGGGAG GAPDH 
FBH1-Fw CCCACACCCACGTCTTCTAT hFbh1 
FBH1-Rev ATGCCACTCTGATGGTTTCC hFbh1 
RAD54-Fw TTTAATTAGCCGGTCCTCTCAA hRad54 
RAD54-Rev ACTGCTGGATTTCCGTTTCCT hRad54 
 
Table 3. siRNAs 
siRNA Sequence Gene 
FBH1-1  GGGAUGUUCUUUUGAUAAAUU hFbh1 
FBH1-2 GUGCCUAUUUGGUGUAAGA hFbh1 
RAD51-1 GAGCUUGACAAACUACUUC hRad51 
RAD51-2  UCUUCCUGUUGUGACUGCCAGGAUA hRad51 
MUS81-1 CAGCCCUGGUGGAUCGAUA hMus81 
MUS81-2 CAUUAAGUGUGGGCGUCUA hMus81 
SMARCAL1-1 GCU UUGACCUUCUUAGCAA hSmarcal1 
SMARCAL1-2 AAGCAAGGCCCAUCCCAAA hSmarcal1 
RAD51AP1 GCAGUGUAGCCAGUGAUUA hRad51AP1 
RAD54 AAAUGCUUCAUGCUGACUGCUGUCC hRad54 
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Table 4. Primary antibodies 
Antibody Use Supplier Ref/Catalogue # 
hMCM2 WB Méndez Lab Ekholm-Reed et al, 2004 
hMCM3 WB Méndez Lab Ekholm-Reed et al, 2004 
mMCM3 WB, IF Méndez Lab Álvarez et al, 2015 
hMCM4 WB Méndez Lab Ekholm-Reed et al, 2004 
mMCM4 WB, IF Méndez Lab Bua et al, 2015 
hMCM6 WB Méndez Lab Ekholm-Reed et al, 2004 
mMCM6 WB Méndez Lab Bua et al, 2015 
PSF2 WB Méndez Lab Aparicio et al, 2009 
CDC45 WB Méndez Lab Aparicio et al, 2009 
ORC1 WB Méndez Lab Mendez et al, 2002 
ORC2 WB, IP Méndez Lab   
CDC6 WB Millipore  05-550 
CDT1 WB Millipore  07-1383 
HA-TAG WB Cell Signaling  2367 
FLAG-TAG WB Cell Signaling  2368 
SMC1 WB Bethyl A300-055A 
SMC1 WB Losada Lab Remeseiro et al, 2012 
MEK2 WB BD 610236 
H3 WB Abcam ab1791 
GMN WB Santa Cruz sc-13015 
BrdU-FITC 
conjugated FACS BD 556028 
BrdU (CldU) IF Abcam ab6326 
BrdU (Idu) IF BD 347580 
ssDNA IF Millipore MAB3034 
pSer10-h3 WB Losada Lab Kimura and Hirano, 2000 
pSer10-H3 WB, IF Abcam ab14955 
pSer10-H3 IHC Millipore 06-570 
γH2AX 
WB, IF, IHC, 
FACS Millipore 05-636 
53BP1 IF Novus Biologicas NB-100-304 
RPA IF Cell Signaling  2208 
ps4/s8-RPA32 WB Bethyl A300-245A 
pS345-CHK1 WB Cell Signaling  2348 
pS15-P53 WB Cell Signaling  92845 
pTyr15-CDK1 WB Cell Signaling  9111 
Cleaved Caspase-3  IHC Cell Signaling  9661 
Ki67 IHC 
Master 
Diagnostica 0003110QD 
p16 IHC 
Monoclonal core 
unit CNIO   
p21 IHC 
Monoclonal core 
unit CNIO   
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SOX9 IHC Millipore AB5535 
RAD51 WB, IF, IP Santa Cruz sc-8349 
RAD51AP1 WB Thermo Fisher PA5-30395 
SMARCAL1 WB Millipore ABE1836 
MUS81 WB Santa Cruz MTA30 2G10/3 
AURORA B IF BD 611082 
 
Table 5. Secondary antibodies 
Antibody Use Supplier Ref/Catalogue # 
Horseradish 
peroxidase–linked 
ECL anti-rabbit IgG  WB GE Heathcare  NA934V 
Horseradish 
peroxidase–linked 
ECL anti-mouse IgG  WB GE Heathcare  NA931V 
anti-rabbit IgG AF-488 
(chicken) IF Invitrogen Molecular Probes  A21206 
anti-rabbit IgG AF-594 
(goat) IF Invitrogen Molecular Probes  A11012 
anti-mouse IgG AF-
488 (goat) IF Invitrogen Molecular Probes  A21121 
anti-mouse IgG AF-
594 (donkey) IF Invitrogen Molecular Probes  A21203 
anti-mouse IgG2a AF-
647 (goat) IF Invitrogen Molecular Probes  A201241 
anti-rat IgG AF-594 
(goat) IF Invitrogen Molecular Probes  A11007 
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RESULTS CHAPTER 1 
 
Mouse models for CDC6 and/or CDT1 overexpression 
Genetically engineered mouse strains that allow the inducible overexpression of Cdc6 
or Cdt1 were generated in the laboratory as part of previous studies (S. Búa, Doctoral 
thesis, UAM 2013). These strains carried cDNAs encoding HA-tagged CDC6 protein or 
FLAG-tagged CDT1 protein at the Collagen 1 A1 (Col1A1) locus, under the control of 
a tetracycline-responsive element (TetO). The transactivator rtTA was knocked-in into 
the Rosa26 locus, and it requires the addition of tetracycline (or its derivative 
doxycycline, dox) to activate expression of the TetO-controlled transgene. This strategy 
allows ubiquitous overexpression of the transgene in a dox-dependent manner (Beard et 
al, 2006; Fig 11A, B). The resultant strains, named TetO-Cdc6 and TetO-Cdt1, could be 
crossbred to generate TetO-Cdc6+Cdt1 mice, which overexpress both transgenes in 
combination. The efficiency of Cdc6 and/or Cdt1 overexpression was evaluated in 
mouse embryonic fibroblast (MEFs) derived from each model (Fig 11C; S. Búa 
Doctoral thesis, UAM 2013). Exogenous proteins are overexpressed approximately 10- 
to 20-fold over endogenous levels after 24h of induction. These protein levels are 
similar to those reported in human cancer cells (5- to 20-fold; Tatsumi et al, 2006).  
 
 
 
FIGURE 11. A. Schematic of the TetO-Cdc6 genetic design. Dox-responsive M2 rtTA is constitutively 
expressed from the Rosa26 promoter (R26p). HA-tagged Cdc6 cDNA is under the control of the rtTA-
responsive operator (TetO) at the Col1A1 locus. pA, polyadenylation signal. B. Schematic for the TetO-
Cdt1 genetic design, similar to that in (A), except that Cdt1 cDNA was tagged with FLAG. TetO-
Cdc6+Cdt1 mice were obtained by crossbreeding TetO-Cdc6 and TetO-Cdt1 strains. C. Immunoblots 
showing expression levels of CDC6 and CDT1 proteins in MEFs derived from TetO-Cdc6 (left), TetO-
Cdt1 (middle) and TetO-Cdc6+Cdt1 mice. In each case, endogenous protein levels are shown in lane 1. 
Lane 2 shows the levels in cells incubated with 1μg/ml dox for 24h. Lanes 3-5 show 50, 25 and 10% of 
the amount of sample loaded in lane 2. MEK2 levels are shown as loading control. 
 
A B 
C 
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Exogenous HA-CDC6 and CDT1-FLAG are regulated as endogenous proteins 
First, the dependency on dox for transgene expression was confirmed using antibodies 
to the HA and FLAG tags. Immunoblots in whole cell extracts from MEFs were 
negative for HA and FLAG signal in the absence of dox, indicating that the TetO 
system is not leaky (Fig 11C). In addition, CDC6 and CDT1 levels in transgenic MEFs 
not treated with dox were comparable to those in WT MEFs (Fig 12A), confirming that 
transgenes were only expressed upon dox addition.  
 
 
A B 
C 
FIGURE 12. A. Immunoblots showing expression levels of CDC6 and CDT1 proteins in MEFs derived 
from TetO-Cdc6, TetO-Cdt1 and WT littermates. For TetO-Cdc6 model, 3 different clones are 
compared to one WT clone. Lanes 1 to 4 shown endogenous CDC6 levels in WT and Tg clones. Lanes 
5 to 8 shows the levels in cells incubated with 1μg/ml dox for 24h. For TetO-Cdt1 model, one WT 
clone (lanes 1 to 3) is compared to 1 transgenic clone (lanes 4 to 6). Lanes 1 and 4 show endogenous 
CDT1 levels for WT and TetO-Cdt1 clones. Lanes 2 and 5 shows the levels in cells incubated with 
1μg/ml dox for 24h. Lanes 3 and 6 shows the levels in cells incubated with 2μg/ml dox for 24h. MEK2 
levels are shown as loading control. B. Upper panel: DNA content profiles of different fractions 
obtained after cell sorting of TetO-Cdc6+Cdt1 MEFs treated or untreated with dox for 24h. Lower 
panel: Immunoblot detection of the indicated proteins after biochemical fractionation of sorted cell 
fractions. Soluble and chromatin-bound fractions are shown. Soluble MEK2 and chromatin-bound H3 
serve as fractionation controls. C. Immunoblot detection of CDC6 and CDT1 proteins after UV 
irradiation in TetO-Cdc6+Cdt1 MEFs. Lanes 1 and 2 show levels in control cells without UV pulse. 
Lanes 3 and 4 show protein levels 30 minutes after a 50J/m2 UV pulse. Lanes 2 and 4 are cells pre 
treated with dox for 24h. MEK2 levels are shown as loading control. 
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Next, several control experiments were performed to evaluate whether exogenous HA-
CDC6 and CDT1-FLAG proteins are still subject to the control mechanisms that 
regulate their endogenous counterparts. First, we investigated the accumulation and 
chromatin-binding dynamics of exogenous proteins in the cell cycle. Control and dox-
treated TetO-Cdc6+Cdt1 MEFs were sorted in G1, S and G2/M phases by DNA content 
and subjected to a biochemical fractionation. Exogenous proteins fluctuated in the cell 
cycle as their endogenous counterparts (Fig 12B). Both proteins distributed between in 
soluble and chromatin fractions and their association to chromatin was similar to the 
endogenous proteins. As expected, CDC6 was less abundant in G1 and remained bound 
to chromatin in S and G2/M phases (Fig 12B; Mendez and Stillman, 2000), whereas 
chromatin-bound CDT1 was degraded in S phase (Fig 12B; Nishitani et al, 2006). Next, 
we checked transgenic protein regulation upon DNA damage. As reported for 
endogenous proteins (Higa et al, 2006; Hall et al, 2007), overexpressed CDC6 and 
CDT1 were partially degraded in cells irradiated with UV (Fig 12C). These experiments 
show that even if they are expressed at higher levels, exogenous HA-CDC6 and CDT1-
FLAG proteins are subject to regulatory mechanisms. 
 
CDC6 overexpression enhances MCM chromatin loading 
To test whether CDC6 or CDT1 overexpression could modify the amount of MCM 
complexes loaded onto DNA, biochemical fractionations were performed in TetO-Cdc6, 
TetO-Cdt1 and TetO-Cdc6+Cdt1 MEFs. As described in the initial characterization of 
these strains (S. Búa, Doctoral thesis, UAM 2013), CDC6 but not CDT1 overexpression 
was sufficient to increase the levels of chromatin bound-MCM complex (Fig 13A, lanes 
7,8 and 9,10). Cooperation was not observed, since the combined overexpression of 
CDC6 and CDT1 did not further increase MCM loading (Fig 13A, lanes 8 and 12). This 
effect of HA-CDC6 protein was confirmed by immunofluorescence detection of 
chromatin-bound MCM3 protein (Fig 13B). These results suggest that CDC6 is a 
limiting factor for origin licensing.  
 
The protein levels of other components of the licensing machinery or the CMG helicase 
remained constant after CDC6 or CDT1 overexpression (Fig 13C), indicating that 
MEFs do not respond to excessive origin licensing by downregulating pre-RC or CMG 
proteins or by upregulating the licensing inhibitor GMN. 
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Combined CDC6 and CDT1 overexpression triggers re-replication in MEFs 
To test the effects of CDC6 and CDT1 overexpression in primary cells, MEFs of the 
three genotypes were cultured in the absence or presence of dox. Incorporation of BrdU 
and cell cycle distribution were assessed by flow cytometry at different times (24, 48 
and 72 hours). No defects in BrdU incorporation or cell cycle distribution were 
observed in TetO-Cdc6 and TetO-Cdt1 MEFs at any time point (Fig 14 and 15). In 
contrast, TetO-Cdc6+Cdt1 MEFs accumulated a population of BrdU-negative cells with 
DNA content >2C but <4C, consistent with partially re-replicated DNA (Fig 14, red 
gates). This population was increased by 5-fold in TetO-Cdc6+Cdt1 treated with dox 
for 24h. The percentage of cells undergoing re-replication was not as high after 72h 
(2.5-fold increase over control cells), but this could be explained by the high confluence 
of cells in the plate at this late time point, which slows down cell proliferation (Fig 14). 
Quantification of the cell cycle phases revealed a decrease in the percentage of G1 cells 
at 24h, (Fig 15). It should be noted that in primary MEF cultures, a small population of 
tetraploid cells frequently coexists with a majority of diploid cells. Importantly, Cdc6 
and Cdt1 overexpression did not induce endoreplication that would result in 
tetraploidization, as the S and G2 phases of the tetraploid cell cycle were invariant in all 
strains independent of dox treatment (Fig 15).  
 
A B C 
FIGURE 13. A. Immunoblot detection of the indicated proteins after biochemical fractionation of 
TetO-Cdc6 (C6), TetO-Cdt1 (C1) and TetO-Cdc6+Cdt1 (C6/C1) MEFs incubated with or without dox 
for 24 h. Soluble and chromatin-bound fractions are shown. Soluble MEK2 and chromatin-bound 
SMC1 serve as fractionation controls. B. High-throughput microscopy (HTM) acquisition of 
fluorescence intensity corresponding to chromatin-bound MCM3 protein in TetO-Cdc6 (C6), TetO-
Cdt1 (C1) and TetO-Cdc6+Cdt1 (C6/C1) MEFs. Three separate experiments were conducted (>900 
nuclei/condition) and a representative result is shown. p-values were calculated using Anova (Kruskal-
Wallis test followed by Dunn’s post-test; ***, p<0.001; n.s., not significant). C. Immunoblot detection 
of the indicated proteins in TetO-Cdc6+Cdt1 MEFs cultured in the presence of dox for 24h. MEK2 
levels are shown as loading control. The experiment was conducted three times with similar results; one 
example is shown. 
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To confirm the existence of re-replication upon combined (but not individual) CDC6 
and CDT1 overexpression, we used an adaptation of the ‘stretched DNA fibers’ assay 
that allows the detection of origin refiring events. In this experiment, cells are pulse-
labelled sequentially with two thymidine analogues that are later detected by 
immunofluorescence (Dorn et al, 2009; Neelsen et al, 2012). To maximize the chances 
of “capturing” events of origin refiring, cells were first pulsed with CldU (magenta) for 
2 h and then with IdU (green) for 30 min. Active replication forks labelled at this time 
are observed as long magenta tracks followed by shorter green tracks. If an origin of 
replication were re-activated in any DNA region already replicated during the first 
pulse, a short green track would be found within the longer magenta track (Fig 16A). 
Using this technique, we found an increased percentage of re-replicated tracks only 
when CDC6 and CDT1 overexpression was combined (Fig 16A), confirming the 
necessary cooperation of both proteins to induce re-replication in primary cells.  
FIGURE 14. Flow cytometry graphs showing BrdU incorporation vs DNA content (propidium iodide, 
PI) in TetO-Cdc6, TetO-Cdt1 and TetO-Cdc6+Cdt1 MEFs grown in media with or without dox at 24, 
48 and 72 hours. The red gate represents a population of cells displaying BrdU-negative cells with DNA 
content between 2C and 4C. Histograms show the percentage of cells within this gate (mean value and 
SD; n=3 assays in each case). Results were analyzed with one-way Anova and Bonferroni’s post test; 
***, p<0.001; n.s.= not significant. 
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It has been described that upon GMN depletion, re-replication mainly occurs from cells 
in the G2 phase of the cell cycle (Klotz-Noack et al, 2012). To check whether this is 
also the case after CDC6 and CDT1 overexpression, EdU incorporation was monitored 
in cells stained with anti-pSer10-H3. This antibody results in specific staining patterns 
in G2 and mitosis (Hendzel et al, 1997). In TetO-Cdc6+Cdt1 MEFs, a 3-fold increase in 
the percentage of cells positive for G2-specific pSer10-H3 and EdU incorporation was 
observed (Fig 16B). This result reflects the existence of unscheduled DNA replication 
during G2. 
 
 
 
 
FIGURE 15. Cell cycle distribution assessed by DNA content of TetO-Cdc6, TetO-Cdt1 and TetO-
Cdc6+Cdt1 MEFs cultured in the absence or presence of dox for 24, 48 and 72 h (n= 3 assays/strain). 
Histograms show the mean percentage values and SD of cells in each phase. White bars represent 
control MEFs, blue bars represent dox-treated MEFs. No statistically significant differences were 
detected between –dox and +dox growing conditions in any population, except when indicated. Results 
were analyzed with one-way Anova and Bonferroni’s post test; *p<0.05; n.s.= not significant. 
tp=tetraploid. 
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Taken together, these results suggest that combined CDC6 and CDT1 overexpression 
induces partial DNA re-replication in primary MEFs. 
 
CDC6 and CDT1 overexpression does not affect S phase entry from quiescence 
To assess whether CDC6 and CDT1 deregulation would affect entry into S-phase in a 
context different from mitotic cell cycles, transgenic MEFs were driven to a G0 state by 
contact inhibition and serum starvation. After 72h in starvation, MEFs were released 
into normal medium in the absence or presence of dox, and BrdU incorporation was 
monitored at different time points (Fig 17A, 18A). CDC6 overexpression did not affect 
the dynamics of cell cycle re-entry, as previously described (S. Búa, Doctoral thesis, 
UAM 2013; Fig 17B). The same result was found after CDT1 overexpression (Fig 
17C). The combined deregulation of CDC6 and CDT1 proteins neither affected the 
kinetics of S phase entry (Fig 18C, D) nor increased re-replication at noticeable levels 
(Fig 18C). It should be noted that HA-CDC6 protein was totally degraded, and CDT1-
FLAG was downregulated in G0 (Figures 17D and 18B; Petersen et al, 2000; Sugimoto 
et al, 2008). The levels of both proteins progressively increased during cell cycle re-
entry (Figures 17D, and 18B) and by 24h post-release their levels were similar to those 
of the asynchronous population. Re-replication was not observed in this experimental 
FIGURE 16. A. Detection of origin re-firing events using stretched DNA fibers. Cells are pulse-
labelled consecutively with CldU (2h; magenta) and IdU (30 min; green). A normal fork results in a 
magenta-green track in the fibers, whereas a re-fired origin creates a short green track over a longer 
magenta track. Histogram shows the mean percentage values and SD of re-firing events (re-replicated 
tracks relative to the total number of green tracks) in TetO-Cdc6 (C6), TetO-Cdt1 (C1) and TetO- 
Cdc6+Cdt1 (C6/C1) MEFs grown in media with or without dox (n= 2 assays/condition; 488-532 green 
track measurements/ condition in each assay). One-way Anova followed by Bonferroni’s post test was 
applied; ***p<0.001; n.s., not significant. B. Representative images of TetO-Cdc6+Cdt1 MEFs, pulse-
labelled with EdU and immunostained for phosphorylated H3 (pH3). DNA was counterstained with 
DAPI. Histogram shows the mean percentage values and SD of cells positive for EdU and pH3 (n=4 
assays. >500 cells/condition were scored in each case. Statistical significance was calculated using 
Student’s t-test; ***, p<0.001). 
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setting, probably because of the limited time in which cells were exposed to high levels 
of CDC6 and CDT1. This result indicates that CDC6 and CDT1 are properly regulated 
during cell cycle exit and re-entry, and reinforces the notion that both are needed to 
promote DNA re-replication.  
 
 
 
 
 
 
 
 
 
 
 
A 
B C 
D 
FIGURE 17. A. Schematic representation of serum starvation and cell cycle re-entry experiment. B. 
Quantification of TetO-Cdc6 BrdU-positive cells at indicated time points corresponding to MEFs growing 
in media with (blue bars) or without (white bars) dox. C. Same as in B for TetO-Cdt1 MEFs. Histograms 
show the mean percentage values and SD of BrdU-positive cells. No statistically significant differences 
were detected at any time point. (n=2 assays. Statistical significance was calculated using Student’s t-test). 
D. Left, immunoblot detection of CDC6 in TetO-Cdc6 MEFs at the indicated time points. Right, 
immunoblot detection of CDT1 in TetO-Cdt1 MEFs at the indicated time points. MEK2 levels are shown 
as loading control. 
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Replication dynamics after CDC6 and CDT1 overexpression 
To evaluate how CDC6 and CDT1 overexpression affected DNA replication dynamics, 
we used the stretched DNA fiber assay to measure fork rate (FR) and inter-origin 
distance (IOD) at single-molecule level. FR serves as an indication of the velocity of 
ongoing forks. In turn, the IOD is proportional to the frequency of origin activation. A 
schematic of the assay and examples of commonly observed structures are depicted in 
Fig 19A, B.  
 
These analyses of replication parameters revealed that TetO-Cdc6 MEFs display shorter 
IOD after CDC6 expression, relative to the control growing conditions in the absence of 
FIGURE 18. A. Schematic representation of serum starvation and cell cycle re-entry experiment. B. 
Immunoblot detection of CDC6 and CDT1 on TetO-Cdc6+Cdt1 MEFs at indicated time points 
growing in media with (+) or without (-) dox. MEK2 levels are shown as loading control. C. Flow 
cytometry graphs showing BrdU incorporation (FITC) vs DNA content (propidium iodide, PI) in 
TetO-Cdc6+Cdt1 MEFs grown in media with or without dox at indicated time points. Gates show 
BrdU positive S phase cells. D. Quantification of TetO-Cdt1 BrdU positive S phase MEFs at indicated 
time points corresponding to MEFs growing in media with (blue bars) or without (white bars) dox. 
Histogram shows the mean percentage values and SD of positive cells. No statistically significant 
differences were detected at any time point. (n=2 assays. Statistical significance was calculated using 
Student’s t-test). 
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dox (79 Kb vs 149 Kb; Fig 19C, left panel). This effect was correlative with the 
increase in MCM loading, as it was also observed in TetO-Cdc6+Cdt1 cells but not in 
TetO-Cdt1 cells (Fig 19C middle and right panels). Therefore, the extra origins licensed 
by CDC6 overexpression are functional and can be activated during S phase. FR was 
decreased in TetO-Cdc6 and TetO-Cdc6+Cdt1 cells  (1.4 vs 0.74 Kb/min and 1.4 vs 1.1 
Kb/min, respectively) while it did not change upon CDT1 overexpression (Fig 19D). A 
direct relationship between FR and IOD is expected (Zhong et al, 2013) as exacerbated 
origin activation affects the dNTPs pool, and/or could activate the checkpoint response, 
slowing down active forks (Petermann et al, 2010; Bester et al, 2011). At least in the 
case of TetO-Cdc6+Cdt1 MEFs, activation of the DNA damage checkpoint in response 
to re-replication could also contribute to the observed effects on fork progression and 
origin activity.  
 
 
Re-replication induces replication stress and DNA damage 
As mentioned in the Introduction, re-replication induces RS and DNA damage. In 
addition, at least one report has suggested that CDT1 deregulation could also induce 
chromosomal damage in the absence of re-replication (Tatsumi et al, 2006). To evaluate 
FIGURE 19. A. Schematic representation of DNA fiber experiment. B. Structures observed and 
measurements in DNA fiber assay. C. Inter-origin distance (IOD) in TetO-Cdc6 (C6), TetO-Cdt1 (C1) 
and TetO- Cdc6+Cdt1 (C6/C1) MEFs grown in media with or without dox. Data from two separate 
experiments are pooled (n=88-106 measurements/condition; p-values were calculated with Mann-
Whitney test; ***, p<0.001; n.s., not significant). D. Fork rate (FR) values in the same MEFs used in 
(C). Data from two separate experiments are pooled (n=584-716 measurements/condition; p-values 
were calculated with Mann-Whitney test; ***, p<0.001; n.s., not significant). 
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these possibilities we measured the levels of H2AX, the phosphorylated form of H2A 
that serves as a marker of RS and DNA damage, using HTM detection. Only dox-
treated TetO-Cdc6+Cdt1 MEFs displayed increased levels of H2AX (Fig 20A). 
H2AX signal did not change in TetO-Cdt1 MEFs, suggesting that in our experimental 
conditions, CDT1 overexpression is no sufficient to induce significant chromosomal 
damage.  
 
 
To confirm that DNA re-replication was the cause of DNA damage observed in TetO-
Cdc6+Cdt1 cells, H2AX signal and DNA content were simultaneously analyzed by 
flow cytometry. As expected, the vast majority of H2AX-positive cells had 2C or >2C 
DNA content (Fig 20B). Importantly, a double IF staining showed that H2AX foci 
colocalized with 53BP1 protein in a high percentage in dox-treated TetO-Cdc6+Cdt1 
MEFs, confirming the presence of DNA DSBs (Fig 21A). We also confirmed that re-
replication induced accumulation of ssDNA, as the percentage of cells positive for RPA 
staining was increased (Fig 21B; S. Búa, Doctoral thesis, UAM, 2013). 
FIGURE 20. A. HTM acquisition of γH2AX fluorescence intensity in TetO-Cdc6, TetO-Cdt1 and 
TetO-Cdc6+Cdt1 MEFs grown in media with (blue dots) or without (black dots) dox. As a positive 
control, MEFs were treated with 2.5 mM HU for 3h (green dots). A representative assay is shown 
(n=3 assays; >1000 nuclei/condition in each assay). Statistical significance was assessed using Anova 
(Kruskal-Wallis test followed by Dunn’s post-test; ***, p<0.001; n.s, not significant). B. Flow 
cytometry analysis of γH2AX vs DNA content (Hoechst) in TetO-Cdc6+Cdt1 MEFs. Gates indicate 
γH2AX-positive cells with DNA content <2C, 2C and >2C. Histogram shows mean percentage 
values and SD of γH2AX-positive cells in each gate (n=3 assays). Statistical significance was 
assessed with One way Anova and Bonferroni’s’s post test; **, p<0.01; n.s., not significant. 
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As expected, the DNA damage checkpoint was activated after Ccd6+Cdt1 
overexpression. Besides H2AX activation, dox-treated TetO-Cdc6+Cdt1 cells showed 
the activating phosphorylation of p53 protein and the inhibitory phosphorylation of 
CDK1 (Fig 21C), indicating a possible block in G2 to prevent that cells carrying re-
replicated DNA progress into mitosis. This was not immediately observed by flow 
cytometry analyses of DNA content (Figure 15). However, when the percentage of cells 
in G2 and M was quantified using specific immunostaining patterns of phospho-H3 
(pH3) and phospho-Aurora B (p-AurB) proteins, we found an increase in G2 and a 
concomitant decrease in mitotic cells (Fig. 22), which likely correspond to the cells with 
re-replicated DNA.  
 
FIGURE 21. A. Representative images of control and dox-treated TetO-Cdc6+Cdt1 cells 
immunostained for γH2AX (red) and 53BP1 (green) proteins. DNA was counterstained with DAPI 
(blue). Scale bar, 25 μm. Histogram shows the mean percentage values and SD of TetO- Cdc6+Cdt1 
MEFs positive for both γH2AX and 53BP1 foci. White bar, control MEFs. Blue bar, dox-treated 
MEFs (n=3 assays; >500 nuclei/condition in each assay; statistical analysis was performed using 
Fisher’s exact test. ***, p<0.001).  B. Representative images of control and dox-treated TetO-
Cdc6+Cdt1 cells immunostained for RPA (red) protein. DNA was counterstained with DAPI (blue). 
Scale bar, 50 μm. Histogram shows the mean percentage values and SD of positive TetO-Cdc6+Cdt1 
MEFs. White bar, control MEFs. Blue bar, dox-treated MEFs. (n=5 assays; 500 nuclei/condition in 
each assay; statistical analysis was performed using Fisher’s exact test. ***, p<0.001). C. 
Immunoblot detection of the indicated proteins in TetO-Cdc6+Cdt1 MEFs cultured in the absence or 
presence of dox for 24h. MEK2 levels are shown as loading control. Samples correspond to the same 
experiment showed in Fig 13C. The experiment was conducted three times with similar results; one 
example is shown. 
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Re-replication decreases cell proliferation and induces apoptosis  
At this time, we wondered if the presence of re-replicated DNA would compromise the 
proliferation capacity of TetO-Cdc6+Cdt1 cells. Proliferation curves indicated that dox-
treated TetO-Cdc6 and TetO-Cdt1 MEFs proliferate at the same rate than their controls 
(Fig 23A, B), whereas CDC6 and CDT1 combined overexpression decreased the 
proliferation rate (Fig 23C). This result is not surprising because TetO-Cdc6+Cdt1 
MEFs displayed DNA damage and a partial G2 arrest. In addition, we asked whether 
cell death could contribute to the slower proliferation dynamics. Apoptotic and dead 
MEFs were detected by flow cytometry after a double staining with TMRE 
mitochondrial dye and DAPI. Dead cells lose the integrity of plasmatic membrane and 
are stained with DAPI, while apoptotic cells lose mitochondrial integrity and cannot be 
stained with TMRE (Fig 24A). Indeed, increased levels of apoptotic activation and cell 
death were observed only when CDC6 and CDT1 were overexpressed in combination 
(Fig 24B, C). 
 
FIGURE 22. A. Representative images of 
control and dox-treated TetO-Cdc6+Cdt1 
cells immunostained for p-AurB (red) 
protein. Scale bar, 50 μm. B. Representative 
images of control and dox-treated TetO-
Cdc6+Cdt1 cells immunostained for G2 
pH3 (red) protein. Scale bar, 50 μm. C. 
Representative images of control and dox-
treated TetO-Cdc6+Cdt1 cells 
immunostained for mitotic pH3 (green) 
protein. Scale bar, 50 μm. In all cases 
histograms show the mean percentage 
values and SD of positive TetO-Cdc6+Cdt1 
MEFs. White bars, control MEFs. Blue bars, 
dox-treated MEFs. n=3 assays. >300 
cells/condition were scored for pAurB. >500 
cells/condition were scored for G2 pH3. 
>1000 cells/condition were scored for 
mitotic pH3. In all cases statistical 
significance was calculated using Student’s 
t-test; *, p<0.05.  
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Combined, the results obtained with MEFs argue that simultaneous deregulation of 
Cdc6 and Cdt1 is necessary to induce re-replication in primary MEFs. Re-replication 
induces RS and DNA damage, leading to checkpoint activation and an increase in 
apoptosis-mediated cell death. 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 23. Proliferation curves of TetO-Cdc6 (n=2 assays), TetO-Cdt1 (n=1 assay) and TetO-
Cdc6+Cdt1 (n=2 assays) cells cultured without or with dox. Mean and SD are represented for 
TetO-Cdc6 and TetO-Cdc6+Cdt1 MEFs. 
 
FIGURE 24. A. Representative flow cytometry graphs showing DAPI staining vs TMRE staining in 
TetO-Cdc6+Cdt1 MEFs grown in media with or without dox at 48 hours. Purple gates represent dead 
cells (permeable to DAPI); red gates represent apoptotic cells (negative for TMRE) and green gates 
represent alive cells (positive for TMRE). B. Histograms show the mean percentage values and SD of 
apoptotic or dead cells in each population, expressed as fold-change with respect to control situation 
(n=3 assays in each case. Results were analyzed with one-way Anova and Bonferroni’s post test; *, 
p<0.05; **, p<0.01; n.s.= not significant).  
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DNA re-replication is lethal during embryonic development 
After evaluating the impact of CDC6 and CDT1 overexpression at the cellular level, we 
decided to investigate whether similar effects would be observed in vivo. Embryonic 
development was tested first, as most tissues are highly proliferative at this stage. A 
mating strategy between TetO-Cdc6 and TetO-Cdt1 mice was designed in which all 
embryos carried both Cdc6 and Cdt1 alleles at Col1A1, but only 50% of them carried 
the rtTA transactivator at Rosa26, providing experimental and control embryos in the 
same litter (Fig 25A). The diet of pregnant mice was supplemented with dox during 
three days in mid gestation (E10.5-E13.5) and the embryos were extracted and analysed 
immediately afterwards. Approximately 50% of them were smaller and paler and 
showed signs of underdevelopment (Fig 25B, top panel). When the dox treatment was 
extended to six days (E7.5-E13.5), these phenotypes were exacerbated and half of the 
embryos were at advanced stages of regression (Fig 25B, bottom panel). Fetal liver cell 
suspensions were prepared from embryos (following a 3-day dox treatment to the 
mother) and labelled with BrdU ex vivo to monitor DNA replication and possible re-
replication. The rest of embryonic tissue was used for genotyping and immunoblotting 
(Fig 25C, D). Remarkably, all embryos expressing rtTA had an increased percentage of 
cells with partially re-replicated DNA (Fig 25C). Overexpression of CDC6 and CDT1 
in these embryos was confirmed by immunoblots in fetal cell extracts (Fig 25D). These 
results suggest that re-replication is incompatible with embryonic development and that 
highly proliferative tissues could be more sensitive to re-replication, as re-replication 
levels were higher in fetal liver cells than in MEFs.  
 
The same strategy was used with the individual overexpressor models. Embryos 
overexpressing CDC6 did not display any abnormalities, and fetal liver cells displayed 
normal DNA content and BrdU incorporation profiles (Fig 26A). Interestingly, CDT1 
overexpressor embryos displayed extensive re-replication in the liver (Fig 26B) after in 
vivo exposure to dox for 3 days and signs of underdevelopment after 6 days (not 
shown). This result is different from MEFs, in which CDT1 overexpression was not 
sufficient to induce re-replication. However, we also observed that the endogenous 
levels of CDC6 in fetal liver cells were much higher than in MEFs, even after dox 
treatment of the latter (Fig 27), whereas CDT1 endogenous levels in MEFs and fetal 
liver cells were comparable. These results imply that endogenous CDC6 levels could 
establish the susceptibility of any given cell type to CDT1 overexpression. We also 
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noticed that GMN levels were elevated in fetal liver cells (Fig 27A), probably to exert a 
stricter control on CDT1 in a cell type that seems to be very sensitive to fluctuations in 
CDT1 levels. 
 
 
 
FIGURE 25. DNA re-replication causes embryonic lethality. A. Schematic of the genetic cross used 
in the experiment. B. Representative TetO-Cdc6+Cdt1 embryos isolated at E13.5, following dox 
administration to the mother for 3 days (upper images) or 6 days (lower images). Molecular 
genotyping at the Rosa26 locus distinguished wild- type (+/+) from Cdc6+Cdt1 overexpressor 
(+/rtTA) embryos; see (D). Bar, 1 cm. C. Flow cytometry analysis of fetal liver cells isolated from 
nine littermate embryos and pulse-labelled with BrdU ex vivo for 30 min. Gates show cells with re-
replicated (>2C) DNA content. D. Top, Rosa26 locus PCR genotype indicates the presence or 
absence of rtTA. Bottom, immunoblots showing protein levels of CDC6, CDT1 and MEK2 (loading 
control) in the liver of the 9 embryos shown in (C). All embryos that carried rtTA (#1-3, 6-8) 
expressed higher levels of CDC6 and CDT1 and underwent DNA re- replication. E. Histogram shows 
the mean percentage and SD of fetal liver cells with >2C DNA content in TetO-Cdc6, TetO-Cdt1 and 
TetO-Cdc6+Cdt1 embryos. See also Fig 26. One litter was evaluated for TetON-Cdc6 mice (n=2 
control and n=6 overexpressors). 2 litters were evaluated for TetON-Cdt1 mice (n= 6 controls and 
n=6 overexpressors). 2 litters were evaluated for TetON-Cdc6+Cdt1 mice (n= 5 controls and n=10 
overexpressors). One way Anova and Bonferroni’s post test were applied; **, p<0.001; **, p<0.01; 
n.s., not significant). C, control; o/e, overexpressor. 
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Cdc6 and Cdt1 overexpression cause rapid morbidity in adult mice 
We next evaluated the effect of Cdc6 and Cdt1 overexpression in young adult mice. For 
this experiment, cohorts of 4 mice from each genotype were fed with dox-supplemented 
diet during 4 weeks (control groups of 4 mice were kept in regular chow diet). Mice 
were sacrificed at the end of the experiment and transgene expression was evaluated in 
FIGURE 26. A. The experiment follows the outline described in Fig 25, using fetal liver cells isolated 
from 8 littermate embryos derived from a cross between TetO-Cdc6 mice, in which only the father 
carried rtTA at Rosa26. 50% of the embryos are expected to overexpress Cdc6. Fetal liver cells were 
pulse-labelled ex vivo with BrdU for 30 min. Gates show cells with >2C DNA content. Top right, 
Rosa26 locus PCR genotype indicates the presence or absence of rtTA. Histogram shows the percentage 
of cells with >2C DNA content. C, control; o/e, Cdc6 overexpression. B. Same as (A), using 7 embryos 
derived from TetO-Cdt1 mice. Statistical significance was calculated using Student’s t-test; ***, 
p<0.001. 
 
FIGURE 27. Immunoblots showing endogenous levels of CDC6, CDT1 
and GMN in fetal liver (FL) cells. For comparison, the levels of the same 
proteins are shown in TetO-Cdc6 MEFs cultured in medium with or 
without dox. MEK2 levels are shown as loading control. 
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multiple organs by RT-qPCR. As expected, Cdc6 was overexpressed in most tissues in 
TetO-Cdc6 and TetO-Cdc6+Cdt1 mice (Fig 28A, C), while Cdt1 was overexpressed in 
TetO-Cdt1 and TetO-Cdc6+Cdt1 mice (Fig 28B, C). Different levels of transgenic 
expression were observed in different tissues, probably due to different efficiency in 
dox delivery. In this regard, virtually no overexpression was detected in brain and 
testes, a known limitation in this method of transgenesis (Beard et al, 2006). We also 
noticed that Cdc6 and Cdt1 mRNA accumulated to lower levels when combined in the 
same model (Fig 28C). 
      
FIGURE 28. Histogram 
showing the fold-change in 
mRNA levels of Cdc6 and 
Cdt1 in different tissues from 
TetO-Cdc6 (A), TetO-Cdt1 
(B), and TetO-Cdc6+Cdt1 
(C) mice after dox 
administration, relative to 
control tissues (n= 4 control 
mice and n=4 dox-treated 
mice). No overexpression 
was detected in brain and 
testes, due to inefficient dox 
delivery to these organs 
(Beard et al, 2006). 
A 
B 
C 
 73 
 
In both TetO-Cdc6 and TetO-Cdt1 strains, control and dox-treated mice showed no 
phenotypic changes for the duration of the experiment. In striking contrast, TetO-
Cdc6+Cdt1 mice showed morbidity signs, including weight loss, as early as 4-5 days 
after dox administration, and their mean survival was less than two weeks (Fig 29A). At 
the time of reaching the humane endpoint, dox-treated TetO-Cdc6+Cdt1 mice displayed 
a reduction of approximately one third of their body weight (Fig 29B). 
 
 
 
Combined Cdc6 and Cdt1 overexpression cause lethal tissue dysplasias  
At the histopathological level, the gastrointestinal (GI) tract of TetO-Cdc6+Cdt1 mice 
was severely dysplastic (Fig 30 and 31). This is the likely cause of death, as it would 
lead to impaired water and nutrient absorption. Besides the GI, tissue alterations were 
observed in the bone marrow (BM), spleen and thymus (Fig 30). 
 
The tisular alterations observed in the intestine of TetO-Cdc6+Cdt1 mice included 
severe nuclear pleomorphism, increased nuclear size and crypt disorganization 
Extensive crypt loss, mucosal atrophy and shortened villi were found throughout the 
entire intestine, with the colon displaying the most severe phenotypes. Dilated crypts 
were filled with cell debris and inflammatory cells. Moderate inflammatory infiltrates 
were also found in the lamina propria (Fig 31).  
 
The stomach of TetO-Cdc6+Cdt1 mice showed related phenotypes, including nuclear 
pleomorphism, increased nuclear size and apoptosis within the glands that lead to 
mucosal atrophy. In some cases, multifocal epithelial hyperplasia and mild 
hyperkeratosis of the non-glandular stomach was observed (Fig 30). 
 
FIGURE 29. A. Kaplan-Meier survival 
curve of TetO-Cdc6+Cdt1 mice (n=16 
control; 20 dox-treated). B. Histogram 
shows mean weight of control and dox-
treated TetO-Cdc6+Cdt1 mice at the 
humane end point (n=15 control; n=16 
dox-treated). Statistical significance was 
assessed with Student’s t-test; ***, 
p<0.001. 
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Moderate spleen atrophy was also observed in TetO-Cdc6+Cdt1 mice. Germinal centers 
were activated, probably to elicit the inflammatory response in the GI tract. The white 
pulp displayed increased apoptosis and decreased follicle size; in addition, the red pulp 
displayed an increment of immature cells with abnormal chromatin patterns. Some 
degree of extramedullary hematopoiesis was observed in dox-treated animals in the 
three groups, and TetO-Cdt1 and TetO-Cdc6+Cdt1 mice showed accumulation of 
erythroid precursors (Fig 30). 
 
In the BM, TetO-Cdc6+Cdt1 mice displayed moderate aplasia, reduction of mature cell 
populations, increased apoptosis and cell nuclei with abnormal chromatin patterns. 
Finally, the thymus of these mice showed severe cortical atrophy, to the extent that the 
organ was practically ablated in some individuals (Fig 30). 
FIGURE 30. Haematoxylin-eosin stainings of indicated tissue sections. BM, bone marrow. In the 
thymus sections, dashed lines indicate the boundary between cortical (top) and medullar (bottom) 
tissue. See text for details. Bars, 50μm. 
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TetO-Cdc6 mice did not present any of these alterations. However, phenotypes similar 
to those described for TetO-Cdc6+Cdt1 mice were also found in TetO-Cdt1 mice, albeit 
much attenuated (Fig 30). For instance, increased immature populations were found in 
the spleen and BM, and multifocal areas of dysplasia were observed in the GI tract. 
Therefore, CDT1 overexpression may be sufficient to induce mild tissue alterations in 
some organs, similar to the situation observed in the fetal liver. Interestingly, all 
affected tissues are highly proliferative, suggesting a relationship between proliferation 
dynamics and sensitivity to CDT1 overexpression. 
 
Notably, organs such as kidney and liver suffered no alterations despite elevated 
transgene expression levels. This rules out a direct correlation between the penetrance 
of dox and the grade of dysplasia observed in different tissues. 
 
DNA re-replication and DNA damage in adult mice tissues 
Some of the cellular phenotypes such as nuclear pleomorphism and increased nuclear 
size could be directly related to DNA re-replication. To demonstrate the existence of 
DNA re-replication in vivo, cells were isolated from the epithelial lining of the intestine 
(Sato and Clevers, 2013) of control and dox-treated TetO-Cdc6; TetO-Cdt1 and TetO-
Cdc6+Cdt1 mice, to evaluate their DNA content by flow cytometry. Only dox-treated 
FIGURE 31. Higher magnification view of control (left) and TetO-Cdc6+Cdt1 (right) mice colon 
tissues shown in Figure 30. A normal intestinal crypt in control tissue is indicated (white dashed 
box). TetO-Cdc6+Cdt1 colon displayed inflammatory infiltrates (black dashed boxes) and global 
disorganization of the crypt structures. Remaining crypts contained few goblet cells, which were 
enlarged (yellow arrows). Some crypts were filled with cell debris (yellow dashed box). Cells with 
increased nuclear size and stippled chromatin were abundant (black arrows). Bar, 50μm. 
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TetO-Cdc6+Cdt1 mice contained a percentage of cells with re-replicated DNA (Fig 
32A). To further confirm this phenotype, confocal microscopy was used to measure the 
DNA content of colon crypt cells stained with DAPI. An analysis of >900 crypt cells 
per condition revealed higher DNA content in dox-treated TetO-Cdc6+Cdt1 mice (Fig 
32B), a result strongly indicative of DNA re-replication in vivo. 
 
 
We then extended the analysis to other tissues. BM cell suspensions were pulse-labelled 
ex vivo with BrdU and stained with PI. As expected, TetO-Cdc6+Cdt1 mice presented 
cells with re-replicated DNA (Fig 33A). In this tissue, TetO-Cdt1 cells also displayed 
some degree of re-replication (Fig 33A), which was not observed in intestinal cells. As 
it was the case of the fetal liver, this effect could be explained by the high expression 
levels of endogenous Cdc6 in the BM (Fig 33B; see Bastian et al, 2008; 
http://bgee.org/?page=gene&gene_id=ENSMUSG00000017499; and Wu et al, 2009; 
http://biogps.org/#goto=genereport&id=23834). 
FIGURE 32. A. Detection of DNA re-replication in crypt-enriched intestinal cells, stained with PI to 
visualize DNA content by flow cytometry. Plot shows Side Scatter Area (SSC-A) vs DNA content 
(PI). Gates include cells with >2C DNA content. Histogram shows quantification of the percentage of 
cells with >2C DNA content (n=4 mice/ strain and condition; One way Anova and Bonferroni’s post- 
test were applied; ***, p<0.001; n.s., not significant). B. DAPI-stained images of crypt cells from 
colon tissue of control and dox-treated TetO-Cdc6+Cdt1 mice. Bar, 30 μm. Box-plot shows the 
integral intensity of DAPI staining in crypt cells from 3 control and 3 dox-treated TetO-Cdc6+Cdt1 
mice. >300 crypt cells were taken from 4 different colon areas in each mouse (>900 crypt cells per 
genotype; statistical significance were calculated with Mann-Whitney test; ***, p<0.001). 
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Finally, the extent of DNA damage caused by re-replication was analyzed by measuring 
the levels of H2AX in different tissues. Combined CDC6 and CDT1 overexpression 
led to DNA damage in colon, stomach and BM (Fig 34). TetO-Cdt1 mice also 
accumulated H2AX-positive cells in the stomach and BM, consistent with partial DNA 
re-replication and limited tissue dysplasia (Fig 34). 
 
 
 
 
FIGURE 33. A. Detection of DNA re-replication in BM cells, pulse-labelled with BrdU ex vivo for 
30 min and processed for flow cytometry. Plot shows BrdU vs DNA content (PI). Gates include cells 
with >2C DNA content. Histogram shows quantification of the percentage of cells with >2C DNA 
content (n=4 mice/strain and condition; One way Anova and Bonferroni’s post-test were applied; 
***, p<0.001; **, p<0.01; n.s., not significant). B. Cdc6 expression levels in different mice tissues as 
shown in Wu et al, 2009 (http://biogps.org/#goto=genereport&id=23834). Embryonic stem cells, 
hematopoietic progenitors, thymocites and BM cells that display the highest Cdc6 expression levels, 
are highlighted.  
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Immunohistopathological characterization of TetO-Cdc6+Cdt1 colon 
To further characterize the consequences of Cdc6 and Cdt1 overexpression in the 
intestine, control and dox-treated TetO-Cdc6+Cdt1 colon sections were stained with 
different cellular markers. Staining with proliferation marker Ki67 was similar in 
control and dox-treated tissues (Fig 35A). SOX9, a marker of precursor cells in the 
intestine (Barker, 2013; Vermeulen and Snippert, 2014), was decreased in dox-treated 
tissue (Fig 35B). This is consistent with the histopathological findings and indicates that 
re-replication interferes with precursor cell maturation. The absence of p16 staining (Fig 
35C) suggests that senescence was not induced, whereas increased p21 staining (Fig 
35D) is indicative of DNA damage checkpoint activation in dox-treated colon cells. 
Although no difference was observed in mitotic index (Fig 35E), pH3 staining revealed 
an increase in the percentage of G2 cells, suggesting a cell cycle arrest (Fig 35F). 
FIGURE 34. γH2AX IHC staining in the indicated tissues of control and dox-treated TetO-Cdc6, 
TetO-Cdt1 and TetO-Cdc6+Cdt1 mice. Scale bar, 50 μm (colon and stomach) and 20 μm (BM). 
Histograms show the mean percentage value and SD of γH2AX-positive area in each case (n=3 
mice/condition; One way Anova and Bonferroni’s post-test were applied; ***, p<0.001; **, p<0.01. 
n.s.= not significant). 
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Finally, an increase in apoptotic cells in the tissue was confirmed with cleaved-Caspase 
3 (Fig 35G). 
 
 
 
 
 
 
 
 
 
FIGURE 35. A. Ki67 IHC staining in colon sections of control and dox-treated TetO-Cdc6+Cdt1 
mice. Scale bar, 50 μm. Histogram shows the mean percentage value and SD of Ki67-positive area. 
B. Same for SOX9. Scale bar, 50 μm. Histogram shows the mean percentage value and SD of SOX9-
positive cell density. C. Same for p16. Scale bar, 20 μm. Histogram shows the mean percentage value 
and SD of p16-positive area. D. Same for p21. Scale bar, 20 μm. Histogram shows the mean 
percentage value and SD of p21-positive area. E. Same for mitotic-specific pH3. Scale bar, 10 μm. 
Histogram shows the mean percentage value and SD of pH3 mitotic cells. F. Same for G2-specific 
pH3. Scale bar, 10 μm. Histogram shows the mean percentage value and SD of pH3 G2 cells. G. 
Same for Cleaved Caspase 3. Scale bar, 20 μm. Histogram shows the mean percentage value and SD 
of CA3-positive cells. For all stainings, n=3 mice per condition. Statistical significance was 
calculated using Student’s t-test; ***, p<0.001; **, p<0.01; *, p<0.05; n.s., not significant. CA3 and 
pH3 staining were scored manually. For CA3, >1400 cells from three different areas were counted in 
each animal. For pH3, >1200 from five different areas were counted in each animal. 
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Interestingly, around 7% of the colon area is positive for Ki67 (Fig 35A) and 2.5% is 
positive for H2AX (Fig 34). This indicates that approximately one third of the 
proliferative cells in the colon display DNA damage, possibly corresponding to those 
most affected by DNA re-replication. 
 
Taken together, these results suggest that unscheduled origin refiring and its associated 
DNA damage cause cell death and loss of progenitor cells in tissues that require rapid 
renovation (such as the intestinal epithelia), rapidly leading to lethal tissue dysplasias. 
 
Long-term effects of single CDC6 or CDT1 overexpression 
As CDT1 overexpression caused limited tissue damage, and considering that 
deregulation of Cdc6 and Cdt1 could promote malignancy (Liontos et al, 2007), we also 
evaluated the long-term effects of Cdc6 or Cdt1 deregulation using the TetO-Cdc6 and 
TetO-Cdt1 mouse strains. In an ageing experiment in which cohorts of TetO-Cdc6 and 
TetO-Cdt1 mice were kept permanently in control or dox-supplemented diet, median 
survival was reduced in approximately 11 weeks in both cases: 102 vs 91 weeks in 
TetO-Cdc6 mice and 93,5 vs 83 weeks in TetO-Cdt1 mice. Although these differences 
in survival did not reach statistical significance (Fig 36A, B), preliminary post-mortem 
analyses suggest a slightly higher frequency of splenomegaly and/or late-onset 
lymphomas in Cdc6 and Cdt1 overexpressor strains. 
 
 
 
FIGURE 36. A. Kaplan-Meier survival curve of TetO-Cdc6 mice (n=30 control; 31 dox-treated). 
Gehan-Breslow-Wilcoxon test was performed and p-value is represented. B. Kaplan-Meier 
survival curve of TetO-Cdt1 mice (n=18 control; 22 dox-treated). Gehan-Breslow-Wilcoxon test 
was performed and p value is represented. 
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RESULTS CHAPTER 2 
 
A screening to identify proteins involved in DNA re-replication control 
In the first part of the Thesis we investigated the in vivo consequences of DNA re-
replication. In the second part, we became interested in identifying proteins that 
participate in the regulation of re-replication. We wondered whether new proteins could 
be identified that control origin re-firing or inhibit the elongation of re-replicated forks. 
Moreover, whether specific molecular mechanisms are in charge of resolving the 
structures generated by origin reactivation remains unknown (Fig 37).  
 
 
 
To address these questions, a genetic screening was designed to identify factors 
involved in inhibiting or promoting DNA re-replication. A candidate-based esiRNA 
library was designed against genes implicated in DNA damage and/or RS response 
(Table 6). The library included RNAi molecules inhibiting three groups of genes. Group 
1 is integrated by helicases with fork remodeling activity. Group 2 are proteins involved 
in DNA damage signalling or repair. These include checkpoint proteins, nucleases with 
the ability to process stalled forks, and HR factors. Group 3 is constituted by helicases 
that act as chromatin remodelers. Our goal was to explore the role of the selected 
proteins in modulating re-replication caused by the disruption of origin licensing. As an 
experimental system amenable to rapid transfection of RNAi reagents, we decided to 
integrate a dox-inducible shRNA molecule targeting GMN in the HCT116 colorectal 
FIGURE37. Schematic representation 
of an origin refiring event leading to 
DNA Re-replication. Potential 
processes to limit re-replication are  
indicated. 
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cancer cell line. In the resultant cells (HCT116-shGMN), re-replication can be readily 
induced by the depletion of GMN, which is the main inhibitor of origin relicensing in 
cancer cell lines (Zhu and DePamphilis, 2009). DNA re-replication elicits an 
enlargement of cell nuclei (Zhu et al, 2004), which could be used as readout of re-
replication after microscopy analyses. We confirmed HCT116-shGMN cells 
downregulated GMN, underwent DNA re-replication and increased nuclear size upon 
dox addition (Fig 38A, B, C).  
 
 
 
A schematic of the experimental plan for the screening is depicted in Fig 38D. HCT116-
shGMN cells were treated with dox to elicit re-replication and then transfected with 
each component of the esiRNA library. 48 hours after transfection, nuclear size was 
evaluated by HTM.  
 
Table 6. List of genes selected for the esiRNA-based library, and their known biochemical activities. 
 83 
 
A large group of the genes tested, particularly the chromatin remodelers, did not affect 
the extent of re-replication, at least as monitored by nuclear size (Fig 39). In contrast, 
several helicases involved in fork remodeling and proteins that participate in the DNA 
damage response (DDR), modulated the process in different ways. In general, the loss 
of helicases increased the nuclear size (Fig 39), suggesting that fork remodelling limits 
re-replication. We focused our attention in two proteins, FBH1 and RAD51, which 
affected re-replication in opposite ways. FBH1 downregulation reduced nuclear size, 
whereas loss of RAD51 increased it (Fig 39). Interestingly, FBH1 is a negative 
regulator of RAD51 (Fig 40). Both RAD51 and FBH1 mediate fork reversal upon 
stalling (Fugger et al, 2015; Zellweger et al, 2015), but an antirecombinase activity in 
FBH1 prevents RAD51-dependent HR (Fugger et al, 2009; Chu et al, 2015). FBH1 can 
displace RAD51 filaments from DNA and monoubiquitilate RAD51 to prevent new 
loading (Fig 40) (Simandlova et al, 2013; Chu et al, 2015).  
 
 
 
 
FIGURE 38. A. Flow cytometry analysis of DNA re-
replication. Graphs show BrdU incorporation vs DNA 
content (propidium iodide, PI) in HCT116-shGMN cells 
grown in media with or without dox for 72 hours. Cells 
in the different phases of cell cycle and cells with DNA 
 content >2C are gated. B. Immunoblot detection of GMN in HCT116-shGMN cells from (A). SMC1 
levels are shown as loading control. C. Representative images of DAPI-stained HCT116-shGMN cells 
grown in media with or without dox for 72 hours. D. Top: Regulation of origin relicensing by GMN. 
Bottom: Schematic representation of the screening designed to test the effect of the library genes in 
DNA re-replication.  
A 
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C 
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FIGURE 39. Screening results. Histogram shows mean of median nuclei area (expressed as fold-
change with respect to control) and SD of each member of the library. –dox and +dox controls are 
shown inside a green rectangle. Red dotted line represents the mean value for +dox (+shGMN) 
condition. Blue dotted lines indicate the SD for this condition. FBH1 and RAD51 results are marked in 
red circles. Different gene groups from the library are indicated with orange lines. (3 replicas of each 
gene were assessed; >900 cells of each replica were scored; results were analyzed with one-way Anova 
and Bonferroni’s post test; ***, p<0.001). 
 
FIGURE 40. Schematic representation of 
FBH1 and RAD51 functions in response to 
DNA damage or RS. Upon fork stalling, 
both proteins are necessary to mediate fork 
reversal. In addition, FBH1 negatively 
regulates RAD51 by displacing it from 
chromatin and by preventing its re-
association with DNA. See text for details. 
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The effects of FBH1 and RAD51 downregulation on cell size upon loss of GMN were 
confirmed with two specific siRNAs (Fig 41), reinforcing the notion that these two 
proteins are involved in re-replication control. 
 
 
 
FBH1 downregulation attenuates re-replication 
To confirm that FBH1 modulates re-replication induced by GMN depletion, BrdU 
incorporation and DNA content were measured by flow cytometry. FBH1 
downregulation was ensured with a combination of two siRNA molecules (Fig 42A). In 
the absence of GMN, FBH1 silencing decreased the percentage of cells with re-
replicated DNA (Fig 42B). Efficient downregulation of GMN and FBH1 was assessed 
by immunoblot and RT-qPCR, respectively (Fig 42C, D). As a control of specificity, we 
confirmed that both siRNAs reduced Fbh1 mRNA and re-replication levels when used 
independently (Fig 43A, B). In subsequent experiments, we used the combination of 
both siRNAs to downregulate Fbh1. 
 
 
 
 
 
 
FIGURE 41. Top: Representative images of 
DAPI-stained HCT116-shGMN cells grown 
in media with or without dox for 72 h and 
treated with the indicated siRNAs. Bottom: 
Histogram shows mean and SD of nuclei 
area. (3 replicas of each condition were 
assessed; >900 cells of each replica were 
scored; results were analyzed with one-way 
Anova and Bonferroni’s post test; ***, 
p<0.001). 
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FIGURE 42. A. Schematic of DNA re-replication detection after gene siRNA downregulation. B. 
Flow cytometry analysis of re-replication in HCT116-shGMN cells grown in media with or without 
dox for 72 h and treated with the indicated siRNAs. Right gate represents cells with over-replicated 
DNA. Histogram shows the percentage of cells within this gate (mean value and SD; n=3 assays; 
results were analyzed with one-way Anova and Bonferroni’s post test; ***, p<0.001; n.s.= not 
significant). C. Immunoblot detection of GMN in HCT116-shGMN cells from (B). MEK2 levels are 
shown as loading control. D. Histogram showing fold-change in Fbh1 mRNA levels relative to 
control in HCT116-shGMN cells from (B). Mean value and SD are shown; n= 3 assays; results were 
analyzed with one-way Anova and Bonferroni’s post test; ***, p<0.001; n.s.= not significant. 
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RAD51 downregulation enhances re-replication 
To confirm the effect of RAD51 downregulation on re-replication, two specific siRNAs 
against RAD51 were used. In the absence of RAD51, the extent of re-replication in 
GMN-depleted cells was increased (Fig 44A), arguing that RAD51 is necessary to limit 
re-replication. When FBH1 and RAD51 proteins were downregulated simultaneously 
the effect of individual RAD51 downregulation was attenuated (Fig 44).  
 
The two RAD51 siRNAs were tested independently to confirm specificity. Both 
siRNAs reduced RAD51 protein levels to a similar extent and led to increased re-
replication (Fig 45). In subsequent experiments, the combination of two siRNAs was 
used to downregulate Rad51. 
 
FIGURE 43. A. Flow cytometry analysis of re-replication in HCT116-shGMN cells grown in media 
with or without dox for 72 h and treated with the indicated siRNAs. Gate includes cells with over-
replicated DNA. Histogram shows the percentage of cells within this gate (mean value and SD; n=3 
assays; results were analyzed with one-way Anova and Bonferroni’s post test; ***, p<0.001; n.s.= not 
significant). B. Histogram showing fold-change in Fbh1 mRNA levels relative to control in HCT116-
shGMN cells from (A). Mean value and SD are shown; n= 3 assays; results were analyzed with one-
way Anova and Bonferroni’s post test; ***, p<0.001; n.s.= not significant. 
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Taken together, these results suggest that FBH1 and RAD51 may be part of a pathway 
that limits DNA re-replication in response to a failure in origin licensing control.  
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 44. A. Flow cytometry analysis of re-replication in HCT116-shGMN cells grown in media 
with or without dox for 72 h and treated with the indicated siRNAs. Right gate includes cells with over-
replicated DNA. Histogram shows the percentage of cells within this gate (mean value and SD; n=3 
assays; results were analyzed with one-way Anova and Bonferroni’s post test; ***, p<0.001; n.s.= not 
significant). B. Immunoblot detection of GMN and RAD51 in HCT116-shGMN cells from (A). SMC1 
levels are shown as loading control. 
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Fbh1 downregulation reduces RS in GMN-depleted cells 
As described above, FBH1 downregulation counteracted re-replication caused by loss of 
GMN. Accordingly, it also reduced the signs of RS and DNA damage in GMN-depleted 
cells, including phosphorylation of RPA32, histone H2AX, CHK1 and p53 (Fig 46A, 
compare lanes 2 and 4). GMN-depleted cells are partially arrested in G2 and this was 
also alleviated by FBH1 downregulation (Fig 46A, compare pH3 signal in lanes 2 and 
4). Reduced RS stress in FBH1-depleted cells was confirmed by flow cytometry 
analysis of H2AX levels (Fig 46B). In contrast, checkpoint activation was not affected 
by RAD51 downregulation, as similar levels of RPA32, CHK1, p53 and histone H3 
phosphorylation were detected (Fig 46A, compare lines 2 and 6).  
 
Because re-replication arises from re-fired origins, we wondered if it would increase the 
number of replication foci. GMN-depleted cells showed more BrdU foci than control 
cells (Fig 47). Notably, FBH1 downregulation restored foci number to control situation 
FIGURE 45. A. Flow cytometry analysis of re-replication in HCT116-shGMN cells grown in media 
with or without dox for 72 h and treated with indicated the siRNAs. Right gate includes cells with over-
replicated DNA. Histogram shows the percentage of cells within this gate (mean value and SD; n=3 
assays; results were analyzed with one-way Anova and Bonferroni’s post test; ***, p<0.001; n.s.= not 
significant). B. Immunoblot detection of GMN and RAD51 in HCT116-shGMN cells from (A). SMC1 
levels are shown as loading control. 
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(Fig 47). In contrast, RAD51 downregulation did not exacerbate the effect of GMN loss 
on replication foci (Fig 47). 
 
 
 
 
 
 
 
 
 
 
Fbh1 downregulation attenuates re-replication independently of Mus81 
FBH1 and MUS81 act together to induce DSBs during the response to RS (Fugger et al, 
2013). To rule out a role of MUS81 in re-replication prevention, we tested how its 
downregulation affects DNA content after GMN loss. Indeed, MUS81 depletion did not 
affect the percentage of cells with re-replicated DNA in the absence of GMN. In 
addition, FBH1 and MUS81 co-depletion did dot further reduce re-replication levels 
(Fig 48) confirming that MUS81 is not implicated in re-replication modulation. 
 
 
 
FIGURE 46. A. Immunoblot detection of the indicated proteins in HCT116-shGMN cells grown in 
media with or without dox for 72 h and treated with the indicated siRNAs.  SMC1 levels are shown as 
loading control. The experiment was conducted twice with similar results; one example is shown. B. 
Flow cytometry analysis of γH2AX vs DNA content (Hoechst) in HCT116-shGMN cells. Gate 
includes γH2AX-positive cells. Histogram shows the percentage of γH2AX-positive cells (mean value 
and SD; n=2 assays; statistical significance was assessed with One way Anova and Bonferroni’s’s post 
test; *, p<0.05). 
 FIGURE 47. Representative 
images of BrdU foci in 
HCT116-shGMN cells grown in 
media with or without dox for 
72 h and treated with the 
indicated siRNAs. Histogram 
shows the number of foci per 
cell (mean value and SD; n=3 
biological replicas; >1000 cells 
scored in each condition and 
each replica; results were 
analyzed with one-way Anova 
and Bonferroni’s post test; ***, 
p<0.001; *, p<0.05; n.s.= not 
significant). 
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GMN-induced re-replication does not promote fork reversal 
In our screening, downregulation of helicases with fork remodelling activities affected 
nuclear size upon GMN loss. This is interesting as both FBH1 and RAD51 are involved 
in fork reversal (Fugger et al, 2015; Zellweger et al, 2015). To clarify whether fork 
reversal is involved in re-replication prevention, we investigated whether this process 
takes place after origin re-firing. We used an indirect assay based on the detection of 
ssDNA that is exposed when newly synthesized strands of different lengths anneal to 
form the characteristic three-way junction (Fig 48A; Couch et al, 2013). In this assay, 
cells are pulse-labelled for 10 min with BrdU after GMN depletion and harvested 1-3 h 
later (Fig 48B). BrdU immunostaining is performed without HCl denaturation, to 
restrict antibody accessibility to ssDNA (Fig 48A).  As positive control, cells were 
treated with 2.5 mM HU in combination with ATR inhibition, as described in Couch et 
al (2013). No changes in “native” BrdU intensity were found after GMN 
downregulation, indicating similar levels of fork reversal in control and re-replication 
FIGURE 48. A. Flow cytometry analysis of re-replication in HCT116-shGMN cells grown in media 
with or without dox for 72 h and treated with the indicated siRNAs. Right gate includes cells with 
over-replicated DNA. Histogram shows the percentage of cells within this gate (mean value and SD; 
n=2 assays; results were analyzed with one-way Anova and Bonferroni’s post test; ***, p<0.001; **, 
p<0.01; n.s.= not significant). B. Immunoblot detection of GMN and MUS81 in HCT116-shGMN 
cells from (A). MEK2 levels are shown as loading control. 
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conditions (Fig 48C, D). Actually, in GMN-downregulated cells, the intensity of native 
BrdU staining was similar to the negative control. We cannot absolutely conclude that 
fork regression does not occur in response to re-replication, as it may take place below 
the detection limit of the technique. However, we postulate that the frequency of these 
structures in response to re-replication is very limited. 
 
 
To further investigate if the extent of re-replication could be limited by fork reversal, we 
tested the effect of SMARCAL1 downregulation. SMARCAL1 mediates fork reversal 
in response to HU-induced RS (Couch et al, 2013). As shown in Fig 50, SMARCAL1 
loss did not significantly change the percentage of re-replicated cells (Fig 50A, B). This 
result reinforces the notion that fork regression is not a major mechanism to prevent 
DNA re-replication. 
 
 
 
 
FIGURE 49. A. Schematic of the anti-BrdU recognition assay in nascent ssDNA at reversed forks. B. 
Timeline of the experiment. C. Representative images of BrdU staining in native conditions of 
HCT116-shGMN cells treated with dox for 3h after the BrdU pulse. Positive control, HCT116-shGMN 
cells treated with 2.5 mM HU in combination with 5 M ATR inhibitor for 4 h D. HTM acquisition of 
BrdU fluorescence intensity in native conditions in HCT116-shGMN cells grown as indicated in (B). 
Median and distribution of BrdU intensities are plotted. Positive control (C+) as in (C). As negative 
control (C-), cells were stained without BrdU labelling. One assay is shown (n=2 assays; >1300 
nuclei/condition in each assay). 
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The role of RAD51 in re-replication control is independent of HR 
The results presented above showed how an anti-recombinogenic protein (FBH1) 
favoured re-replication while a pro-recombinogenic one (e.g. RAD51) limited it. 
Therefore, we next asked whether the functions of FBH1 and RAD51 in modulating re-
replication required HR. If this was the case, we reasoned that depletion of other HR 
proteins that operate downstream of RAD51 should render similar effects in terms of re-
replication. RAD51AP1 was chosen to explore this possibility, as it co-operates with 
RAD51 during strand invasion and stabilization of the D-loop (Wiese et al, 2007; Daley 
et al, 2013; Fig 51A). We found that, upon GNN downregulation depletion of 
RAD51AP1 did not affect the percentage of cells with re-replicated DNA (Fig 51B, C), 
suggesting that strand invasion reaction and HR are not necessary to restrict re-
replication. 
 
 
 
 
 
 
 
 
FIGURE 50. A. Flow cytometry analysis of re-replication in HCT116-shGMN cells grown in media 
with or without dox for 72 h and treated with the indicated siRNAs. Right gate includes cells with 
over-replicated DNA. Histogram shows the percentage of cells within this gate (mean value and SD; 
n=3 assays; results were analyzed with one-way Anova and Bonferroni’s post test; ***, p<0.001; 
n.s.= not significant). B. Immunoblot detection of GMN and SMARCAL1 in HCT116-shGMN cells 
from (A). MEK2 levels are shown as loading control. 
A B 
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RAD51 binds to chromatin during the S-phase 
None of the canonical FBH1 and RAD51 functions seemed to be involved in prevention 
of re-replication, so we entertained another possibility. FBH1 might be a general 
regulator of the stability of RAD51 on chromatin, not only at stalled forks, as described 
to date. In turn, chromatin-bound RAD51 might be responsible of limiting the extent of 
re-replication following aberrant origin licensing and re-firing.  
 
This model predicts that RAD51 binds to chromatin even in an unperturbed S phase. 
This hypothesis was tested by IF stainings of chromatin-bound RAD51 in the presence 
or absence of GMN. PCNA staining allowed differentiating the cells undergoing S 
phase. With this approach, we first confirmed that re-replication increased nuclear 
RAD51 intensity and induced the formation of RAD51 foci due to the generation of 
DSBs (Fig 52A, B; Melixetian et al, 2004; Zhu and Dutta 2006). In control conditions, 
FIGURE 51. A. Schematic of the role of RAD51AP1 in the strand invasion step of HR. B. Flow 
cytometry analysis of re-replication in HCT116-shGMN cells grown in media with or without dox for 
72 h and treated with the indicated siRNAs. Right gate includes cells with over-replicated DNA. 
Histogram shows the percentage of cells within this gate (mean value and SD; n=3 assays; results 
were analyzed with one-way Anova and Bonferroni’s post test; n.s.= not significant). C. Immunoblot 
detection of GMN and RAD51AP1 in HCT116-shGMN cells from experiment showed in (B). MEK2 
levels are shown as loading control.  
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PCNA-positive cells displayed higher intensity of RAD51 than PCNA-negative cells 
(Fig 52C). Most of the RAD51 signal was not concentrated in foci but rather distributed 
through chromatin (Fig 52A, upper panel). This result suggests that a fraction of 
RAD51 binds to DNA during unchallenged S phase and possibly has functions outside 
recombination foci.  
 
 
The kinetics of RAD51 chromatin binding in unperturbed cells was evaluated by 
biochemical fractionation in cells sorted in the G1, S and G2/M phases of the cell cycle 
(Fig 52D). GMN, CDC6, CDT1 and MCM2 proteins are shown as controls since they 
behave as expected (reviewed by Arias and Walter, 2007). Higher levels of RAD51 on 
chromatin were found in S and G2/M than in G1 (Fig 52D) suggesting that RAD51 is 
recruited to chromatin during the S phase. Considering that the RAD51 staining pattern 
FIGURE 52. A. Representative images of control and dox-treated (72 h) HCT116-shGMN cells, 
immunostained for chromatin-bound RAD51 (green) and PCNA (red) proteins. DNA was 
counterstained with DAPI (blue). Scale bar, 15μm. B. Plot shows the median and the distribution of 
RAD51 intensity in the cells used in (A). 8013 and 4034 nuclei in each condition respectively; 
statistical analysis was performed using Mann-Whitney test; ***, p<0.001). C. Plot shows the median 
and the distribution of RAD51 intensity in PCNA-negative and PCNA-positive HCT116-shGMN 
control cells 4960 and 3053 nuclei in each condition respectively; statistical analysis was performed 
using Mann-Whitney test; ***, p<0.001). D. Upper panel, DNA content profiles of asynchronous 
HCT116-shGMN control cells and the different fractions obtained after cell sorting. Lower panel, 
immunoblot detection of the indicated proteins after biochemical fractionation of sorted cells. 
Chromatin-bound fraction is shown. GMN, CDC6, CDT1 and MCM2 proteins serve as control of cell 
cycle position. Chromatin-bound H3 levels serve as loading control. 
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is pan-nuclear during S phase (Fig 52A) and that HR did not influence re-replication, 
we hypothesize that the fraction of RAD51 that is associated to chromatin but not 
enriched in foci might be responsible for limiting re-replication.  
 
 
 
 
 
 
 
 
 
Interestingly, RAD51 has been detected at ongoing replication forks by iPOND 
(Zellweger et al, 2015) and it interacts with several MCM subunits (Shukla et al, 2005) 
Based on these antecedents, it is possible that RAD51 also binds to replication origins. 
To test this hypothesis, RAD51 was overexpressed in a cell population enriched in S 
and G2 by thymidine ‘block and release’ (Fig 53A). Reciprocal immunoprecipitation 
FIGURE 53. A. Upper panel, schematic of the experiment. Lower panel, DNA content profile of 
HCT116-shGMN cells after thymidine (Thy) block and release. Gates include G1 cells (left) and 
S/G2/M cells (right). B. Immunoprecipitation (IP) assays using IgG, hORC2 and hRAD51 
antibodies, in HCT116-shGMNN cells transfected with pDEST47-RAD51 plasmid and enriched 
in S/G2/M phases. IP samples, input (2% of the amount used in the IP) and flow-through (FT) 
samples were analyzed by immunoblot with the indicated antibodies. Asterisks mark RAD51 and 
ORC2 interaction. C. Venn diagrams showing overlap between hRAD51, hORC2 and SNS 
genomic positions as indicated. Percentages are relative to ORC2 positions (top and middle 
panels) and ORC2+SNSs positions (down panel). See text for details. 
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(IP) reactions revealed an interaction between RAD51 and endogenous ORC2 (Fig 
53B).  
 
Available data about RAD51 occupancy on chromatin (RAD51 ChIP-seq from 
ENCODE project, GEO accession nr GSE91838) further support the notion that 
RAD51 binds to replication origins. A comparison of RAD51 ChIP positions and ORC2 
binding sites (Miotto et al, 2016) in K562 cells indicated that >67% (35180) of ORC2 
positions contained RAD51 (Fig 53C). Intriguingly, only 16% (8292) of the defined 
ORC2 positions overlapped with short-nascent DNA strands (SNS) mapped in a 
separate study (Picard et al, 2014). However, almost 80% (6567 peaks) of these bona 
fide replication origins (positive for both Orc2 and SNS) contained RAD51 (Fig 53C).  
 
Taken together, these experiments suggest that a population of RAD51 binds to 
chromatin during the S phase that is not organized in recombination or repair foci. We 
propose that this population plays a role in the control of DNA re-replication. 
 
Stabilization of RAD51 on chromatin reduces re-replication 
In our model, the lack of FBH1 would stabilize RAD51 on chromatin, resulting in lower 
re-replication levels. In fact, this effect has been documented in different systems 
(Fugger et al, 2009; Simandlova et al, 2013). In our cellular system, FBH1 
downregulation increased the IF signal of chromatin-bound RAD51 in S phase cells 
(Fig 54). 
FIGURE 54. Representative images of HCT116-shGMN cells treated with FBH1 siRNA for 48 h, 
immunostained for chromatin-bound RAD51 (green) and PCNA (red) proteins. DNA was 
counterstained with DAPI (blue). Scale bar, 15 μm. Histogram shows the median and the 
distribution of RAD51 intensity from PCNA-positive cells. 3053 and 1939 nuclei in each condition 
respectively; statistical analysis was performed using Mann-Whitney test; ***, p<0.001). 
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We reasoned that other treatments that modulate the stability of RAD51 on chromatin 
should have an influence in re-replication levels. Different strategies were used to test 
this hypothesis. First, we tested RAD51 mutant versions in the ATPase domain (Fig 
55A) that affect its ability to form functional filaments (Stark et al, 2004; Chi et al, 
2006; Kim et al 2012). RAD51 K133A mutant is defective for ATP binding and K133R 
mutant is unable to hydrolyse ATP. Both mutants in Lys133 are dominant-negative 
when co-expressed with endogenous RAD51 (Kim et al 2012), preventing the efficient 
formation of RAD51 filaments (Stark et al, 2002; Stark et al, 2004; Laulier et al, 2011; 
Kim et al 2012). When these mutants were transfected in HCT116-shGMN cells and 
tested in the DNA re-replication assay, both of them increased the extent of re-
replication caused by GMN loss (Fig 55B, C, D). This result suggests that RAD51 
ATPase activity and formation of functional filaments are necessary to limit re-
replication. 
 
 
FIGURE 55. A. Schematic of RAD51 primary structure. HhH (Helix-hairpin-Helix) DNA binding 
domain, Walker A and B motifs are indicated. Lysine 133 is located in the Walker A motif. The 
conserved domain between RecA and Rad51 is represented in blue. B. Immunoblot detection of GMN 
and RAD51 mutants in HCT116-shGMN cells 48 h after a single transfection with pDEST47-RAD51 
expressing either WT, K133A (KA) or K133R (KR) mutant forms of RAD51. Ponceaus staining is 
shown as loading control. C. DNA profiles measured by Hoechst signal of HCT116-shGMN cells 
grown in media with or without dox for 72 h and transfected with the indicated plasmids. Right gate 
includes cells with >2C DNA content. D. Histogram shows the percentage of cells with >2C DNA 
content (mean value and SD; n=2 assays; results were analyzed with one-way Anova and Bonferroni’s 
post test; ***, p<0.001; *, p<0.05). 
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FIGURE 56. Flow cytometry analysis of re-replication in HCT116-shGMN cells grown in media 
with or without dox for 72 h and treated with 7.5µM RS1 for the last 24 h. Right gate includes cells 
with over-replicated DNA. Histogram shows the percentage of cells within this gate (mean value 
and SD; n=3 assays; results were analyzed with one-way Anova and Bonferroni’s post test; ***, 
p<0.001; **, p<0.01). 
FIGURE 57. A. Schematic of RAD54 role in destabilizing RAD51 nucleofilaments on DNA. Taken 
from Heyer et al. (2010). B. Histogram shows RAD54 mRNA levels (fold-change relative to control) 
in HCT116-shGMN cells. C. Flow cytometry analysis of re-replication in HCT116-shGMN cells 
grown in media with or without dox for 72 h and treated with the indicated siRNAs. Right gate 
includes cells with over-replicated DNA. Histogram shows the percentage of cells within this gate 
(mean value and SD; n=3 assays; results were analyzed with one-way Anova and Bonferroni’s post 
test; ***, p<0.001; **, p<0.01). 
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As a second approach, cells were treated with RS-1, a drug that stabilizes RAD51 
binding to ssDNA (Jayathilaka et al, 2008). RS-1 slightly reduced re-replication levels 
caused by GMN loss (Fig 56). Finally, we tested the effect of RAD54, a translocase 
responsible for destabilizing RAD51 filaments on dsDNA (Solinger et al, 2002; Shah et 
al, 2010; Ceballos and Heyer, 2011; Fig 57A). In the absence of a good antibody for 
RAD54, the efficiency of siRNA was tested by mRNA levels (Fig 57B). Interestingly, 
we found that in the absence of GMN, a 50% downregulation of RAD54 mRNA was 
sufficient to reduce the percentage of re-replicated cells (Fig 57C). Taken together, 
these results suggest that stabilization of RAD51 protein on chromatin contributes to 
limit DNA re-replication. 
 
MCM binding to chromatin does not influence re-replication levels 
Because RAD51 interacts with ORC and MCM, we wondered whether FBH1 or 
RAD51 downregulation might affect the binding of pre-RC proteins or the CMG 
helicase complex to the DNA. Biochemical fractionation assays showed that upon 
GMN depletion, the amount of pre-RC components on chromatin was reduced (Fig 58, 
compare lanes 1 and 2). This effect can be explained because GMN protects a fraction 
of CDT1 protein from degradation during G2 and M, facilitating licensing in the next 
G1 phase (Ballabeni et al, 2004). As expected, not only CDT1 but also MCM 
components were slightly less abundant in the chromatin fraction of GMN-depleted 
cells (Fig 58). Although CDC6 binding to DNA is independent of CDT1, at least in 
yeast (Yeeles et al, 2015), we found that CDC6 chromatin association was also affected 
by GMN depletion. 
 
FBH1 or RAD51 downregulation did not affect CDC6 or CDT1 binding to chromatin 
(Fig 58, compare lanes 1 and 3; 1 and 5). Unexpectedly, downregulation of RAD51 
slightly increased the amount of chromatin-bound MCM proteins, but not CDC45, 
another component of the CMG helicase. Therefore, the number of active helicases 
might not increase. As CDC6, CDT1 or CDC45 DNA binding are virtually not affected 
by RAD51 downregulation, the effect of RAD51 on re-replication is not likely to be 
mediated by changes in origin licensing. The increase in MCM loading could be caused 
by fork stalling associated to re-replication or alterations in cell cycle progression. 
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The fact that MCM levels do not correlate with re-replication seems counterintuitive. 
We considered the possibility that re-replication depends on the unscheduled 
association of MCM complexes with the DNA (e.g. during S or G2) rather than their 
absolute amount. To test this idea, we evaluated whether GMN depletion could still 
induce re-replication after siRNA-mediated MCM downregulation. Indeed, GMN 
depletion induced substantial re-replication even after a significant reduction (>90%) in 
FIGURE 58. Immunoblot detection of the indicated 
proteins after biochemical fractionation of HCT116-
shGMN cells grown in media with or without dox for 
72 h and treated with the indicated siRNAs. 
Chromatin-bound fraction is shown. H3 is shown as 
loading control. 
FIGURE 59. A. Flow cytometry analysis of re-replication in HCT116-shGMN cells grown in media 
with or without dox for 72 h and treated with the indicated siRNAs. Right gate includes cells with 
over-replicated DNA. Histogram shows the percentage of cells within this gate (mean value and SD; 
n=3 assays; results were analyzed with one-way Anova and Bonferroni’s post test; ***, p<0.001; **, 
p<0.01). B. Immunoblot detection of GMN and MCM2 in HCT116-shGMN cells from (A). MEK2 
levels are shown as loading control. 
A B 
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MCM2 protein (Fig 59). This result suggests that some replication origins might have 
particularly high affinity for MCMs and could be relicensed despite of the reduction in 
MCM concentration. Accordingly, yeast cells contain origins that are prone to re-
replication and are characterized by specific sequences called re-initiation promoters 
(Richardson and Li; 2014). 
 
RAD51 blocks the progression of re-replicated forks  
At this point we considered the possibility that RAD51 might block the progression of 
forks originated form re-fired origins. Origin activity and fork progression rate (FR) 
were monitored using stretched DNA fiber assays (Fig 60A) to explore this possibility. 
 
 
GMN depletion reduced fork speed (Fig 60B, C). This result was expected considering 
that re-replication induces DNA damage (Neelsen et al, 2013) that slows replication 
forks (Seiler et al, 2007). In control cells, FBH1 and RAD51 downregulation slightly 
FIGURE 60. A. Representation of the DNA fiber experiment B. Examples of DNA fiber images 
from the indicated cells. Bar, 20 M C. Histogram shows the median and the distribution of FR 
values in HCT116-shGMN cells grown in media with or without dox for 72 h and treated with the 
indicated siRNAs. Data from three separate experiments are pooled (n>900 measurements/condition; 
p-values were calculated with Mann-Whitney test; ***, p<0.001; **, p<0.01). D. Histogram shows 
the percentage of origin firing in the same cells used in (C). Mean value and SD; n=2 assays. 500 1st 
label structures/condition were measured in each assay; p-values were calculated with one-way 
Anova and Bonferroni’s post test; **, p<0.01;n.s., not significant. 
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diminished FR, suggesting that both factors may facilitate fork progression during S 
phase (Fig 60C). Interestingly, in re-replication conditions, RAD51 downregulation 
markedly increased fork speed (Fig 60B, C). Considering that RAD51 downregulation 
only had a limited effect on FR in control cells, we reasoned that the effect observed 
upon GMN loss might be due mainly to re-replicated forks. Moreover, RAD51 
depletion in control cells did not change origin activity, while in the absence of GMN it 
reduced origin activation, which is consistent with the increased FR (Zhong et al, 2013). 
These results point out to a function of RAD51 in impeding fork progression. 
 
 
 
To confirm that RAD51 specifically blocks the progression of forks originated from 
refired origins we evaluated the length of re-replicated tracks in single molecules, using 
the variation of the DNA fiber assay described in the first chapter of Results (Fig 61A, 
FIGURE 61. A. Detection of re-replication using stretched DNA fibers. Schematic of the experiment 
and representation of observed structures B. Examples of HCT116-shGMN cells grown in media with 
or without dox for 72 h and treated with RAD51 siRNA. Bar, 5 M C. Histogram shows the 
percentage of re-firing events (re-replicated tracks relative to the total number of green tracks) in 
HCT116-shGMN cells (mean value and SD; n= 3 assays; 394-551 green track 
measurements/condition in each assay; n>1400 total green tracks scored in each condition; one-way 
Anova followed by Bonferroni’s post test was applied; *, p<0.05; n.s., not significant). D. Plot shows 
the length of re-replicated tracks in the same cells used in (C). The median and the distribution of 
lengths are plotted. Data from three different experiments are pooled (mean value and SD; 111, 234, 
139 and 280 re-replicated tracks were measured respectively in each condition; Mann-Whitney test 
was applied; ***, p<0.001; n.s., not significant). 
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B). As expected, the percentage of re-replicated tracks was similar when GMN was 
depleted alone or in combination with RAD51 (Fig 61C), arguing against a regulation 
of origin re-firing. In contrast, re-replicated tracks were much longer when RAD51 was 
absent (Fig 61B, D). This result provides direct evidence that chromatin-bound RAD51 
during S phase limits re-replication by hindering the progression of re-replicated forks. 
 
MRE11 is involved in the degradation of re-replicated DNA 
A HR-independent role for RAD51 during DNA replication was proposed in X. laevis, 
consisting in the protection of nascent strands from MRE11 nuclease degradation 
(Hashimoto et al, 2010). We wondered if MRE11 might participate in re-replication 
control, possibly by degrading the re-replicated strands. The role of MRE11 was 
evaluated in GMN-depleted cells using mirin, a chemical inhibitor of MRE11 (Dupré et 
al, 2008). Indeed, MRE11 inhibition resulted in a higher percentage of cells with 
partially re-replicated DNA (Fig 62A). When MRE11 and RAD51 were simultaneously 
downregulated, the percentage of cells with over-replicated DNA was further increased 
(Fig 62B).  
 
 
 
 
 
within this gate (mean value and SD; n=3 assays; results were analyzed with one-way Anova and 
Bonferroni’s post test; ***, p<0.001; **, p<0.01). Immunoblot shows GMN downregulation. B. Flow 
cytometry analysis of re-replication in HCT116-shGMN cells treated with the indicated siRNAs, 
grown in media with or without dox for 72 h and treated with 10µM mirin for the last 24 h. Right gate 
includes cells with over-replicated DNA. Histogram shows the percentage of cells within this gate 
(mean value and SD; n=2 assays; results were analyzed with Student’s t-test; *, p<0.05). 
FIGURE 62. A. Flow 
cytometry analysis of re-
replication in HCT116-shGMN 
cells grown in media with or 
without dox for 72 h and 
treated with 10µM mirin for 
the last 24 h. Right gate 
includes cells with over-
replicated DNA. Histogram 
shows the percentage of cells 
A 
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Origin re-firing promotes the accumulation of ssDNA gaps by unknown mechanisms 
(Neelsen et al, 2013). If MRE11 degrades re-replicated DNA, we reasoned that end 
resection might be a source of ssDNA. In this case, inhibition of MRE11 should 
increase the levels of re-replicated DNA without increasing the amount of ssDNA. This 
possibility was investigated by measuring ssDNA levels by BrdU native detection in 
cells treated with mirin (Fig 63A). We confirmed that GMN depletion leads to ssDNA 
accumulation (Fig 63A, lanes 1 and 2). As anticipated, MRE11 inhibition did not 
further increase the amount of ssDNA (Fig 63A, lanes 2 and 4).  
FIGURE 63. A. Left panel, schematic of the experiment. Right panel, HTM acquisition of BrdU 
fluorescence intensity in native conditions in HCT116-shGMN cells grown in media with or without 
dox and treated with 10µM mirin for 24 h. Median and distribution of BrdU intensities are plotted. As 
positive control, cells were treated with 2.5 mM HU for 24 h (C+). As negative control, the BrdU 
labelling step was omitted (C-). A representative assay is shown (n=3 assays; >1900 nuclei/condition 
in each assay). Statistical significance was assessed using Kruskal-Wallis test followed by Dunn’s 
post-test; ***, p<0.001; n.s, not significant. B. Detection of re-replication using stretched DNA 
fibers. Schematic of the experiment: Dox-treated and RAD51-depleted HCT116-shGMN cells are 
treated or not with 10µM mirin for 24 h and pulse labelling with CldU (2h; pink) and IdU (30 min; 
green). C. Plot shows the length of re-replicated tracks in the indicated cells. The median and the 
distribution of lengths are plotted. Data from two different experiments are pooled (178 and 190 total 
re-replicated tracks were measured respectively in each condition; Mann-Whitney test was applied; 
***, p<0.001). 
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Finally, to confirm that MRE11 degrades over-replicated DNA, we evaluated the length 
of re-replicated tracks in GMN and RAD51 co-depleted cells treated with the MRE11 
inhibitor (Fig 62B). After 24 h of mirin treatment, re-replicated tracks were significantly 
longer (Fig 62C), confirming that MRE11 participates in the clearance of re-replicated 
DNA. 
 
Taken together, our results indicate that disruption of licensing control by ablation of 
GMN causes the reactivation of some replication origins during S or G2. In these 
circumstances, RAD51 and MRE11 participate in backup mechanisms to limit the 
progression of re-replicated forks and degrade the over-replicated DNA. 
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DISCUSSION 
 
Mouse models to study the effects of deregulated origin activity 
The consequences of origin licensing disruption have been extensively addressed in cell 
lines (reviewed by Hills and Diffley, 2014). Several MCM-deficient mouse models that 
address the effects of insufficient origin activity have also been generated. These mice 
display RS, DNA damage, stem cell deficiency, hematopoietic defects and cancer 
susceptibility (Shima et al, 2007; Pruitt et al, 2007; Chuang et al., 2010; Kunnev et al, 
2010; Alvarez et al, 2015). In contrast, mouse strains that allow the study of origin over-
activity were missing. A mouse model in which Cdc6 was over-expressed in the skin 
under the control of the keratin 5 (K5) promoter has recently been described in our lab 
(Búa et al, 2015). K5-CDC6 mice showed increased MCM loading in keratinocytes, but 
origin hyper-activation was not reported. It was also noted that Cdc6 overexpression 
sensitized the skin to carcinogen agents, facilitating papilloma formation (Búa et al, 
2015). 
 
The TetO-Cdc6 and TetO-Cdt1 mice that we have used in this work are the first tools to 
investigate the impact of pre-RC proteins overexpression in the whole organism. 
Interestingly, our models may lead to two different types of origin deregulation: while 
Cdc6 overexpression increased the frequency of origin activation in a controlled manner 
(Fig 19C), combined overexpression of Cdc6 and Cdt1 led to origin re-firing (Figures 
14, 16). The consequences for mice survival were drastically different (Figures 29, 36). 
 
Origin re-licensing and DNA re-replication in vivo 
We have shown that Cdc6 overexpression, but not Cdt1, increased MCM loading on 
chromatin (Fig 13A). Moreover, DNA fiber assays showed that these extra origins are 
functional and can be activated in S phase (Fig 19C). These observations suggest a 
hierarchy in the origin licensing process in which Cdc6 would be a limiting factor. We 
propose a model in which CDC6 limits the number of licensed origins during G1, while 
CDT1 protein would be in excess. At this stage, the concentration of CDC6 is tuned to 
ensure a proper amount of replication origin licensing (Fig 64A). It should be noted that 
in G1, CDT1 protein is not strongly regulated while CDC6 levels are limited by the 
action of APC/Cdh1 (Figures 5, 17D and 18B) (Petersen et al, 2000; Sugimoto et al, 
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2008). In this scenario, additional (overexpressed) CDC6 is capable of licensing more 
origins during G1 (Fig 64B). Importantly, elevated levels of CDC6 induced more MCM 
loading only in G1, and did not facilitate origin refiring because CDT1 is inhibited and 
degraded in S phase (Fig 64A, B). 
 
When CDT1 is overexpressed, neither increased origin licensing nor origin refiring 
were observed, because CDC6 levels would be still limiting both in G1 and S phases 
(Fig 64C). Therefore, ectopic CDT1 expression in S phase is not sufficient to induce re-
replication in primary cells.  
 
 
 
Finally, when both CDC6 and CDT1 are overexpressed, more origin licensing and 
origin re-firing events were observed (Fig 64D). We propose that primary cells have a 
“double-check” mechanism to prevent DNA re-replication. In agreement with this 
model, GMN depletion is not sufficient to induce DNA re-replication in primary cells 
(Zhu and DePamphilis, 2009). In contrast, silencing of APC/Cdh1 inhibitor Emi1, 
efficiently induce re-replication in non-tumoral cells (Machida and Dutta, 2006; Lee et 
FIGURE 64. A. Model of the 
origin licensing process in 
G1. A hypothetical region is 
drawn with two potential 
origins marked by ORC 
complexes. The levels of 
CDC6 protein are limiting for 
pre-RC formation in G1, and 
only one origin is licensed 
and activated in S phase. 
After G1/S, both CDC6 and 
CDT1 proteins become 
limiting. B. After deregulated 
Cdc6 expression, more 
origins are licensed in G1 and 
fired in S phase. However, no 
re-replication occurs because 
CDT1 protein is still limiting 
after G1/S. C. After 
deregulated Cdt1 expression, 
the situation is similar to the 
WT cells because CDC6 is 
limiting. D. After the 
combined deregulation of 
Cdc6 and Cdt1, both proteins 
are available to facilitate 
origin re-licensing and re-
replication in S phase. 
 
A 
 
C 
 
B 
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al, 2012). Emi1 downregulation decreased both GMN and Cyclin A levels (Fig 65), 
disrupting both CDC6 and CDT1 levels (Machida and Dutta, 2006).  
 
 
 
 
Implications for CDC6 as origin licensing limiting factor 
The fact that more MCM loading is observed when CDC6 is overexpressed opens two 
interesting questions: First, how and where are these new origins licensed? Second, how 
do cells respond to these extra origins?  
 
Regarding the first question, it seems that Cdc6 overexpression is able to create new 
functional origins. During licensing, MCM, CDC6 and ORC ATPase activities load the 
MCM hexamer and releases CDT1 from the origin (Fernández-Cid et al, 2013; Coster et 
al, 2014; Kang et al, 2014). MCMs may travel passively on DNA once loaded (Powell 
et al, 2015). It is conceivable that additional CDC6 levels result in the loading of more 
than one MCM double hexamer in each origin. The extra MCM double hexamers would 
move away of the loading site and relocate to other regions where they could be later 
activated during the S phase.  
 
Another possibility is that not all chromatin-bound ORC sites are able to recruit CDC6. 
This implies that some potential origins cannot be licensed during G1 (Fig 64A). 
However, in the presence of additional CDC6, these potential origins would be licensed 
(Fig 64B). Additional experiments, ideally the elucidation of high-definition maps of 
ORC, CDC6 and MCM binding sites, will be needed to better understand this issue.  
 
Since excessive origin activity has been linked to RS (Bester et al, 2011; Jones et al, 
2013; Hills and Diffley, 2014), the anticipated answer to the second question would be 
that dox-treated TetO-Cdc6 MEFs should display RS. However, these cells exhibit 
FIGURE 65. Schematic of CDC6 and 
CDT1 regulation by EMI1 through the 
APC/C complex. EMI1 restrains APC/C 
activity during S and G2 phases. When 
EMI1 is downregulated, APC/C is 
activated and GMN and CycA are targeted 
to degradation. In the absence of these 
proteins, CDC6 and CDT1 activity in S 
and G2 phases can lead to origin re-
licensing. 
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H2AX levels comparable to control cells (Fig 20A), arguing that, within certain limits, 
primary cells are able to cope with different levels of origin activation. Supporting this 
notion, progenitor cells have different requirements for origin activity during the 
process of hematopoietic differentiation (Alvarez et al, 2015). Therefore, the prevailing 
view that excessive origin activation induces RS needs to be reconsidered. The ability 
of CDC6 to change the amount of licensed origins at G1 provides a tool to control these 
fluctuations. By modulating CDC6 levels, cells could change origin activity to adapt 
replication to differentiation programmes and/or proliferation requirements (Fig 66). 
 
Re-replication sensitive cells 
In this study, we have reported apparent exceptions to our model, e.g. fetal liver cells 
and adult BM cells displayed re-replication in response to Cdt1 overexpression alone 
(Figures 26B and 33A). Interestingly, we found that endogenous CDC6 levels in fetal 
liver WT cells were higher than in dox-treated MEFs (Fig 27). Moreover, Cdc6 mRNA 
levels are high in hematopoietic progenitors and BM cells (Fig 33B; Wu et al, 2009; 
http://biogps.org/#goto=genereport&id=23834). 
 
In general, cells with fast proliferation cycles display higher CDC6 levels (Fig 66) to 
facilitate the licensing of more replication origins that would be needed to support rapid 
proliferation. At the same time, these cells would be more sensitive to re-replication, as 
prevention of origin re-licensing would depend only on CDT1 regulation. We propose 
that beyond a threshold level of CDC6 protein levels, deregulation of CDT1 is sufficient 
to induce DNA over-replication (Fig 66).  
 
This view is supported by several published studies.  First, embryonic stem cells show 
rapid proliferation and have adapted their cell cycle by increasing the levels of CDC6, 
CDT1 and GMN (Fuji-Yamamoto et al, 2005; Ballabeni et al, 2011). Interestingly, 
ESCs and embryonal carcinoma cells are strongly dependent on GMN to prevent DNA 
re-replication, and this control is no longer essential when ESCs differentiate in vitro 
(Yang et al, 2011; Huang et al, 2015). Second, leukocyte precursors undergo re-
replication in the absence of GMN (Shinnick et al, 2010) and genetic ablation of GMN 
reduces mature hematopoietic cells (Karamitros et al, 2015). While this study suggests a 
transcriptional role for GMN that is responsible for the phenotype, additional effects on 
re-replication cannot be excluded. Finally, many tumoral cells have high levels of 
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CDC6 (Tatsumi et al, 2006; Petrakis et al, 2016), and this fact could explain their 
sensitivity to Cdt1 overexpression or GMN downregulation (Vaziri et al, 2003; 
Melixetian et al, 2004).  
 
 
 
Re-replication induces severe dysplasia in proliferative tissues 
We have found that combined Cdc6 and Cdt1 overexpression induces severe dysplasias 
in several proliferative tissues and reduces the lifespan of adult mice (Figures 29A and 
30). We demonstrated that TetO-Cdc6+Cdt1 MEFs experience DNA re-replication 
(Figures 14 and 16) and exhibit features of cells with over-replicated DNA: RS, DNA 
damage, G2 arrest and apoptosis (Figures 20 to 24). We have also shown that DNA re-
replication is extensive in fetal liver of developing embryos (Fig 25) and we found 
evidence of limited but consistent re-replication in adult tissues such as the intestine and 
the BM (Figures 32 and 33). In agreement with cellular data, IHC stainings showed that 
re-replication induced extensive DNA damage, activation of DNA damage response, a 
partial G2/M arrest and cellular apoptosis in intestinal tissue (Figures 34, 35).  
 
It seems intriguing that a relatively low percentage of the intestinal cells underwent 
DNA re-replication (less than 5% of the population, as measured by flow cytometry) 
elicits these severe defects. In this regard, it should be noted that there are detection 
limits to the level of re-replication that can be measured. When DNA content is 
FIGURE 66. Re-replication sensitive cells. Cells may adjust pre-RC protein levels (especially 
CDC6) to their proliferation requirements and/or developmental programme. In cells with lower 
proliferation rate, deregulation of Cdc6 and Cdt1 is necessary to override licensing control and 
induce re-replication. On the other hand, cells with higher proliferation rate (e.g. fetal liver 
progenitor cells, tumoral cells) and higher levels of endogenous CDC6 are susceptible to individual 
Cdt1 deregulation. In the latter, the control mechanisms that restrict CDT1 activity become 
essential. 
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measured by flow cytometry, only cells with a fair amount of over-replicated DNA will 
be considered positive, whereas cells that undergo single events of origin refiring may 
escape detection. A similar detection problem has been reported when using 
comparative genomic hybridization (Green et al, 2006). In fact, the DNA fiber assay 
allows detection of DNA re-replication at levels that would be undetectable by flow 
cytometry (Dorn et al, 2008). This technique showed that >15% of total replicating 
forks were originated from refired origins in dox-treated TetO-Cdc6+Cdt1 MEFs (Fig 
16A). Interestingly, approximately one third of proliferating cells in the colon were 
positive for H2AX (Figures 34 and 35). In BM, H2AX staining is positive in 15% of 
the total tissue area in some individuals, even if < 4% of the cells displayed re-
replication levels that could be measured by flow cytometry (Figures 33A and 34). 
Considering these evidences, it could be argued that a significant number of cells were 
affected by re-replication in mice tissues. 
 
Different mechanisms have evolved to prevent or minimize the extension of aberrant 
DNA re-replication (reviewed by Arias and Walter, 2007). Surprisingly, the GI tract 
tissues showed a strong sensitivity to DNA re-replication, with dramatic consequences 
for survival. In humans, the whole intestinal epithelium is replaced within 
approximately 5 days (Barker, 2013; Vermeulen and Snippert, 2014). Differentiation of 
progenitor cells to mature cells normally involves several rounds of cell division (Zhu 
and Skoultchi, 2001; Barker, 2013). Hematopoietic and intestinal stem and progenitor 
cells are sensitive to DNA re-replication (Figures 30, 35 and 66; Shinnick et al, 2010; 
Huang et al, 2015; Karamitros et al, 2015). Therefore, tissue cell renewal will be rapidly 
compromised by re-replication, and a blockage of cell supply is likely to cause 
extensive tissue damage in just a few days, as observed in our mouse model. 
 
DNA over-replication and cancer  
CDC6 and CDT1 have been proposed to have oncogenic properties, based on multiple 
lines of evidence: both proteins are overexpressed in several types of tumours and 
precancerous lesions (Ohta et al, 2001; Bonds et al, 2002; Karakaidos et al 2004; Xouri 
et al, 2004; Bravou et al, 2005; Murphy et al, 2005; Pinyol et al, 2006; Liontos et al, 
2007; Petrakis et al, 2016) likely due to gene amplification (Liontos et al, 2007). It has 
been proposed that aberrant CDC6 expression could inhibit the transcription of 
p16INK4 and CDH1 (Gonzalez et al, 2006; Sideridou et al 2011) and overexpression of 
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CDC6 in the skin of mice favours papilloma formation upon DMBA-TPA treatment 
(Búa et al, 2015). CDT1 overexpression in thymocytes promotes lymphoma 
development in the absence of p53 (Seo et al, 2005), and nude mice injected with 3T3 
fibroblasts overexpressing CDT1 develop tumours (Arentson et al, 2002). Moreover, re-
replication induced by CDT1 may favour carcinogenesis after papillomavirus infection 
(Fan et al, 2013). CDC6 and CDT1 overexpression promotes genome instability and 
malignant behaviour in papilloma premalignant cells (Liontos et al, 2007). Finally, in a 
subset of p53-null atypical carcinoma cells, chronic p21 expression results in CDC6 and 
CDT1 deregulation and cells display aggressive behaviour (Galanos et al, 2016). 
 
Here, we have addressed the carcinogenic potential of CDC6 and CDT1 overexpression 
by performing ageing experiments in TetO-Cdc6 and TetO-Cdt1 mice. Individual 
overexpression of these proteins did have a modest impact on spleen size and tumour 
formation and overall survival was only marginally affected (Fig 36A, B). These results 
strongly suggest that the presumed oncogenic activity of CDC6 and CDT1 
overexpression observed in cellular systems probably requires additional genetic 
alterations. Consistent with this notion, previous studies only reported tumour formation 
in immunocompromised mice, mice with mutant backgrounds or in the presence of 
other carcinogens (Arentson et al, 2002; Seo et al 2005; Búa et al, 2016). 
 
In yeast, DNA re-replication induces gene amplification and chromosomal instability 
(Green et al, 2010; Hanlon and Lee, 2015), two frequent features of cancer cells 
(Hanahan and Weinberg, 2011). Whether re-replication is sufficient to promote cell 
transformation or contributes to tumour development has not been formally addressed in 
mammalian systems. Despite the fact that CDC6 or CDT1 overexpression are 
tumorogenic when combined with other oncogenic features, re-replication has not been 
reported within tumours (Arentson et al, 2002; Seo et al 2005; Liontos et al, 2007; Búa 
et al, 2016).  
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According to our data, the notion that re-replication might lead to cell transformation 
must be taken with caution. We found that combined deregulation of CDC6 and CDT1 
in the mice induced levels of DNA re-replication that were lethal during embryonic 
development and also in adult mice, not allowing the study of tumour formation 
(Figures 25 and 29A). Interestingly, dox-treated TetON-Cdt1 mice had an essentially 
normal lifespan, even if re-replication and DNA damage were detected in several tissues 
after the first month of treatment (Figures 33 and 34). This suggests that mice tissues 
may tolerate limited amounts of re-replication, at least in the absence of additional 
genetic alterations. We consider two non-exclusive possibilities: (a) re-replication is 
more prevalent than previously acknowledged, and can be tolerated to some extent; (b) 
those cells that re-replicate DNA undergo apoptosis and are removed from the tissue. In 
support of the first possibility, short DNA fragments seem to accumulate at origins 
during initiation of DNA replication (Gómez and Antequera, 2008). In support of the 
second scenario, the final outcome of cancer cells when re-replication is induced is cell 
death, rather than survival with increased genomic instability (Vaziri et al, 2003; 
Melixetian et al, 2004; Zhu and DePamphilis, 2009). These ideas are summarized in our 
working model (Fig 67). Normal tissues tolerate some degree of origin relicensing and 
re-replication. In precancerous cells that have accumulated mutations, origin relicensing 
may induce a higher degree of re-replication that may contribute to genome instability 
and transformation. In turn, tumoral cells with high levels of pre-RC proteins such as 
CDC6 become very sensitive to origin reinitiation, probably because excessive DNA re-
replication causes cell death.  
FIGURE 67. Differential outcomes of re-replication. In normal cells, re-replication is largely limited by 
multiple mechanisms. Precancerous lesions are closer to the “CDC6 threshold” that facilitates re-
replication. In those cells, re-replication may contribute to accumulate genomic instability. Finally, 
cancer cells display high levels of preRC proteins and are strongly dependent on GMN activity. CDT1 
overexpression, GMN depletion or disruption of other regulatory mechanisms rapidly induce extensive 
DNA damage and lead to cell death. 
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Genetic screenings for modulators of DNA re-replication 
In recent years, high-throughput screenings have been designed that uses as readout the 
nuclear DNA content of individual cells using laser scanning cytometer technology (Lee 
et al, 2012). This method has been applied to identify cell cycle or mitotic regulators 
(e.g. Mukherji et al, 2006; Kittler et al, 2007) and more recently, small molecules and 
genes that induce DNA re-replication (Zhu et al, 2011; Vassilev et al, 2016). Vassilev et 
al (2016) have recently identified 42 genes that prevent excessive DNA replication that 
could be caused by re-replication or endoreplication. Re-replication is promoted by 
origin refiring and leads to cells with incomplete DNA ploidy (between 2C and 4C). In 
contrast, endoreplication is produced by two or more rounds of complete genome 
duplication without intervening cytokinesis, leading to cells whose DNA content is a 
multiple of 2C (Zielke et al, 2013). From the 42 reported genes, only 7 were involved in 
the control of re-replication, through previously described mechanisms that inhibit 
origin relicensing. The remaining 35 genes were involved in mitotic processes and their 
absence promoted endoreplication instead of re-replication (Vassilev et al, 2016). 
 
The screening presented in Chapter 2 of this Thesis was carried out in HCT116 colon 
cancer cells, the same cell line used in the study by Vassilev et al (2016). HCT116 cells 
display little or no chromosomal instability, are competent for the DNA damage 
checkpoint and sensitive to GMN depletion. A fundamental difference between our 
approach and that of Vassilev et al (2016) is that we aimed at the identification of 
proteins that play a role in controlling the extent of re-replication after it has been 
triggered by GMN depletion. In this type of screening, targeting GMN provided several 
advantages. First, as opposed to other genes whose ablation causes re-replication (e.g. 
CDT2, SKP2 or EMI1), GMN downregulation does not interfere with protein 
ubiquitilation, reducing the risk of indirect effects. Second, GMN may have extra-
replicative roles during embryonic development but not in adult differentiated cells 
(Gonzalez et al, 2006; Yang et al 2011; Yellajoshyula et al, 2011; de Renty et al 2014).  
 
Our candidate-based library was designed to evaluate the participation of the selected 
proteins in promoting or limiting re-replication, but also in the potential processing of 
over-replicated DNA. Interestingly, neither FBH1 nor RAD51 had been identified in 
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previous screenings (Vassilev et al, 2016), probably because their downregulation has 
virtually no effect in DNA content in the presence of GMN (Figures 42 and 44).  
 
Amongst other proteins that prevent DNA re-replication we found three helicases with 
fork remodelling activity, two proteins involved in ICL repair, one RNA helicase, and 
two components from the nucleotide excision repair (NER) pathway. Fewer proteins 
were found that enhanced DNA re-replication, including one chromatin remodeler 
(ATRX), and one RAD51-interacting protein (RAD54).  
 
Chromatin remodelers had a minimal impact on GMN-dependent re-replication with the 
exception of ATRX, which increased the extent of re-replication. ATRX is responsible 
for H3.3 deposition in heterochromatin and telomeres (Watson et al, 2015). In contrast, 
several fork-remodelling proteins might contribute to limit re-replication especially 
BLM, WRN, ZRANB3 and to a lesser extent BRIP, ASCC3, HELQ and SETX. BRIP1 
(FANCJ) belongs to FA pathway and interacts with BRCA1 during ICL repair (Hiom, 
2010), ASCC3 is needed for DNA alkylation repair (Dango et al, 2011), HELQ together 
with RAD51 paralogues promotes ICL repair (Adelman et al, 2013; Takata et al, 2013) 
and SETX is involved in R-loop unwinding (Alzu et al, 2012). The links between these 
processes and re-replication prevention will require validation and additional study.  
 
The three main structure-specific endonucleases MUS81, SLX4 and GEM1 are not 
likely involved, while exonucleases may have a limited effect in re-replication 
promotion. The role of Rad54, a protein related to RAD51 function, is discussed later. 
Finally, a possible role of nucleotide excision repair (NER) proteins should also be 
considered, as two members of this pathway (ERCC2 and ERCC3) restrained re-
replication in our screening. 
  
As it occurs in every genetic screening, possible hits are to be confirmed and validated 
to rule out false positives, e.g. those caused by RNAi inespecificity or in this specific 
case, by any gene involved in the control of nuclear size independently or DNA 
replication. In this work, we focused in the validation and further investigation of the 
roles of FBH1 and RAD51 proteins. 
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DNA re-replication and fork reversal 
RAD51 is required for fork reversal in response to different genotoxic agents 
(Zellweger et al, 2015). In addition, three helicases with fork remodelling activities 
(BLM, WRN and ZRANB3) are likely to prevent re-replication (Fig 39) and all of them 
participate in the restart of stalled forks (reviewed by Muñoz and Mendez, 2016). So, it 
could be argued that generation of reversed forks restricts DNA re-replication. 
However, downregulation of other proteins involved in this process, e.g. RECQ1, 
RECQ5 or SMARCAL1, did not affect nuclear size upon GMN loss (Fig 39). Actually, 
a possible role of SMARCAL1 in the control of DNA re-replication was ruled out by 
evaluation of DNA content (Fig 50). In addition, FBH1 favours re-replication despite its 
role in promoting fork reversal. 
 
We found no evidence of reversed forks after GMN downregulation using a published 
method based on BrdU detection in native conditions (Couch et al, 2013; Fig 49). 
However, we cannot exclude the possibility that fork reversal occurs below the 
detection limit of this technique. Further investigation on this issue would require 
electron microscopy (EM) detection of these structures. Intriguingly, two studies that 
have used EM to detect fork reversal in cells undergoing re-replication have yielded 
different results. In the first study, re-replication caused by EMI1 depletion led to an 
accumulation of these structures (Neelsen et al, 2013). In the second study, using a cell 
line that displayed re-replication associated to Cdc6 and Cdt1 overexpression (Galanos 
et al, 2016) the percentage of reversed forks was lower than in control cells. While our 
results do not support a role of fork reversal in the control of re-replication, further 
experiments will be required to clarify this aspect. 
 
A model for RAD51 prevention of DNA re-replication 
Direct evaluation of re-replication by DNA content confirmed that RAD51 prevents re-
replication while FBH1 promotes it (Figures 42 to 45). FBH1 downregulation not only 
decreased re-replication but also attenuated its consequences (Figures 46 and 47). Other 
proteins necessary for strand invasion such as RAD51AP1 were not involved in re-
replication prevention, suggesting a recombination-independent mechanism (Fig 51). 
We have also shown that a fraction of RAD51 is bound to chromatin during S phase and 
could be located to replication origins (Figures 52, 53). Furthermore, changes that affect 
the stability of RAD51 on chromatin were immediately reflected in changes in the 
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extent of re-replication in the absence of GMN (Figures 54 to 57). Importantly, RAD51 
downregulation increased fork rate and the length of re-replicated tracks only when 
GMN is not present (Figures 60 and 61). In agreement with this result, it has been 
recently described that physiological re-replicated fork progression in D. melanogaster 
follicle cells is enhanced in the absence of RAD51 homologs (Alexander et al, 2016). 
Finally, we have observed that MRE11 inhibition also increases the percentage of cells 
with over-replicated DNA and the length of re-replicated tracks (Figures 62, 63). Taken 
together, these results have led us to propose the following model (Fig 68): after regular 
origin firing, RAD51 would be recruited to the newly synthesized DNA, possibly 
through its interaction with ORC2. RAD51 filaments could probably stretch from the 
origins to nearby regions. In the event of aberrant origin refiring, the presence of 
RAD51 on chromatin would serve as a brake to limit the progression of re-replicated 
forks (Fig 68). In this scenario, the action of antirecombinases and translocases that 
displace RAD51 nucleofilaments would promote the elongation of re-replicated forks. 
Finally, MRE11 and other nucleases may contribute to restrain re-replication by 
resecting re-duplicated strands after RAD51 is displaced from DNA. 
 
 
 
 
Figure 68. Schematic of RAD51 acting as a molecular brake for re-replicated forks. ORC may 
facilitate RAD51 binding to replication origins and chromatin in S phase, to protect newly 
synthesized DNA from nucleolytic degradation. FBH1 and possibly other helicases might counteract 
RAD51 binding to chromatin.  In the event of origin refiring, RAD51 blocks the progression of re-
replicated forks.  
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This model represents a novel mechanism that limits DNA re-replication when licensing 
control fails. This mechanism might be important to restrict genomic instability in 
precancerous cells with high levels of licensing proteins (Petrakis et al, 2016). 
 
In the next section, some aspects about RAD51 recombination-independent roles and 
their connections with our model are discussed. 
 
Recombination-independent RAD51 functions 
RAD51 is the main recombinase involved in strand invasion during HR (reviewed in 
Heyer et al, 2010) and participates in DSB repair, ICL repair, fork restart and template 
switching reactions (Branzei and Foiani, 2010; Petermann and Helleday, 2010; Gaillard 
et al, 2015). In recent years, recombination-independent roles for RAD51 have been 
described; such as promoting fork reversal (Zellweger et al, 2015) and protecting stalled 
and reversed forks from nucleolitic degradation (Schlacher et al, 2011, 2012). In 
addition, experiments in X. laevis suggested that RAD51 protects nascent strands and 
promotes continuous synthesis in the unperturbed S phase (Hashimoto et al, 2010).  
 
We have identified a novel recombination-independent role of RAD51 in blocking the 
elongation of re-replicated forks (Fig 68). To perform this role, RAD51 should bind to 
newly duplicated chromatin during S phase (Fig 52). In agreement with this notion, X. 
laevis RAD51 binds to undamaged chromatin during S phase, and its binding is 
prevented by inhibition of origin assembly or firing (Hashimoto et al, 2010). 
Furthermore, RAD51 signal can be detected in unchallenged EdU-positive cells (Fugger 
et al, 2009; Zellweger et al, 2015), and it binds to chromatin in S phase in synchronized 
U2OS cells (Somyajit et al, 2015). Moreover, in human and mouse cells, RAD51 
immunoprecipitated with nascent DNA in iPOND experiments (Kim et al, 2012; 
Somyajit et al, 2015; Zellweger et al, 2015). RAD51 also precipitated with mature DNA 
suggesting that it remains temporarily bound to duplicated DNA (Zellweger et al, 
2015). Finally, loss of FBH1 increases RAD51 signal in the absence of RS (Fugger et 
al, 2009; Simandlova et al, 2013).  
 
The presence of RAD51 on chromatin in regular S phase imposes the necessity to 
strictly regulate its recombinogenic function, since unscheduled HR is detrimental for 
the cells (reviewed by Carr and Lambert, 2013). Several antirecombinases are 
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responsible for this control, and whether they affect re-replication remains unknown. 
For instance, we have observed that RAD51 eviction by FBH1 and RAD54 favours 
DNA re-replication (Fig 42, 54 and 57). Nonetheless, our screening results suggested 
that some helicases with antirecombinase functions as BLM or BRIP might prevent 
DNA re-replication (Fig 39). Therefore, the impact of each individual antirecombinase 
on the extent of DNA re-replication extent should be further investigated. 
 
Another aspect of this HR-independent RAD51 function is the nature of the protein(s) 
responsible for RAD51 DNA loading. RAD51 paralogs, RAD52 and BRCA2 facilitate 
RAD51 loading on DSBs (reviewed by Heyer et al, 2010). In turn, BRCA1, BRCA2 
and FA proteins are needed for RAD51-mediated protection of stalled forks, suggesting 
a role in RAD51 loading (Schlacher et al, 2011, 2012). Similar results were obtained for 
RAD51 paralogs (Somyajit et al, 2015) and for WRN and WRNIP1 (Su et al, 2014; 
Leuzzi et al, 2016). It remains unknown whether any these proteins mediate the binding 
of RAD51 to origins and nascent strands in S phase. Interestingly, in our screening 
WRN downregulation affected re-replication in a similar way as RAD51 (Fig 39) 
suggesting that it could participate in the loading or stabilization of RAD51 on DNA. 
Finally, RAD51 could interact with ORC2 to facilitate its binding to origins (Fig 53B). 
So far, there is only indirect evidence for this, but it is worth noting that most of bona 
fide replication origins identified by combination of ORC2 binding sites and SNS 
contained RAD51 (Fig 53C).  
 
Role of exonucleases and DNA re-replication 
We have also identified an unanticipated role for MRE11 nuclease in the resection of 
re-replicated DNA (Fig 62, 63). MRE11 possesses 3’-5’ exonuclease (Paul and Gellert; 
1998) and endonuclease activities (Cannavo and Cejka; 2014). At DSBs, MRE11 
performs an endonucleolytic cleavage 100 to 300 nt away from the DSB and then starts 
short-range 3’-5’ resection, while other exonucleases perform 5’-3’ long range resection 
(Cejka, 2015). We propose that MRE11 might operate at re-replicated DNA in a similar 
way. Consistently with a role in resection of re-replicated DNA, we found that MRE11 
inhibition by mirin duplicated the levels of re-replication, without changing the amount 
of ssDNA (Figures 62 and 63A). This result suggests that one of the causes of ssDNA 
accumulation during DNA re-replication is MRE11-dependent resection of re-
duplicated DNA. 
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In any case, the changes observed in re-replicated track length upon MRE11 inhibition 
(Fig 63C) would require the participation of long-range resection nucleases or possibly 
multiple MRE11 nucleases performing endonucleolytic cleavage at different points in 
the same over-replicated DNA. In our screenings downregulation of most exonucleases, 
including MRE11, did not affect nuclear size (Fig 39). Whether MRE11 or other 
nucleases have effects on nuclear size that are independent or DNA re-replication 
remains to be elucidated.  
 
Re-replication: An “Achilles heel” of cancer cells? 
Some of the work presented in this Thesis and other recent studies invite to consider the 
possibility that re-replication might be used to kill cancer cells. It was described several 
years ago that GMN-induced re-replication preferentially kills cancer over primary cells 
(Zhu and DePamphilis, 2009). Another example is MLN4924, a drug that inhibits 
neddylation and activation of culling-RING ubiquitin ligases including CRL4 (Soucy et 
al, 2009; Milhollen et al, 2011). MLN4924 promotes the accumulation of CDT1, SET8 
and p21, favouring re-replication and efficiently killing cancer cells (Lin et al, 2010; 
Milhollen et al, 2011; Benamar et al, 2016). Interestingly, FBH1 is also targeted for 
degradation by CRL4 complex (Bacquin et al, 2013) so its accumulation may contribute 
to DNA re-replication. MLN4924 has been shown to be effective against different 
tumoral cells (Pan et al, 2013; Benamar et al, 2016; Zhang et al, 2016; Guo et al, 2017) 
and is currently used in clinical trials in patients with metastatic melanoma (Bhatia et al, 
2016).  
 
Our study with mouse models supports this strategy. The susceptibility of any given cell 
type to DNA re-replication seems to correlate with its rate of proliferation (Fig 66). We 
have shown that CDT1 activity could be unleashed in mice without severe phenotypes 
(Fig 30, 36B). For this reason, deregulation of CDT1 might induce lethal re-replication 
in tumour cells with a limited impact in the surrounding healthy tissues. RAD51 is 
overexpressed in several cancer cell lines (Raderschall et al, 2002), and its role in 
limiting re-replication could be particularly important for these cells. Therefore, 
interventions on RAD51 chromatin binding might enhance DNA re-replication in 
tumoral cells. It could be interesting to use this strategy to treat tumours characterized 
by elevated expression of pre-RC components (Karakaidos et al, 2004; Galanos et al, 
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2016) or by mutations in BRCA1/2 that could affect RAD51 loading onto DNA 
(Fackenthal and Olopade 2007). 
 
We believe that the mice strains characterized in this work, TetON-Cdt1 and TetON-
Cdc6+Cdt1, could be useful to test this strategy in pre-clinical studies with chemical 
carcinogens or after crossbreeding with cancer-prone mouse models. Future in vivo 
experiments will determine whether re-replication caused by deregulated origin activity 
can be considered a cancer “Achilles heel”. 
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CONCLUSIONS 
 
1. In primary cells, CDC6 protein is limiting for origin licensing and frequency of 
origin activation. 
2. In primary cells, DNA re-replication is only observed after the combined 
deregulation of CDC6 and CDT1. 
3. Overexpression of CDT1 (alone or in combination with CDC6) causes DNA re-
replication in fetal liver cells and is lethal during embryonic development. 
4. CDC6 and CDT1 can be efficiently overexpressed in many tissues of adult mice: 
individual CDC6 or CDT1 overexpression does not cause major phenotypes and 
mice lifespan is only marginally reduced. 
5. Combined CDC6 and CDT1 overexpression induces re-replication and lethal 
dysplasia in several tissues, mainly stomach, intestine, spleen and bone marrow. 
Dysplasia of the intestinal epithelium proves fatal in less than two weeks. 
6. CDC6 endogenous levels determine cell susceptibility to re-replication induced 
by deregulation of CDT1 
7. A genetic screening has identified RAD51 and FBH1 as proteins involved in the 
control of DNA re-replication upon loss of geminin. 
8. The role of RAD51 in preventing DNA re-replication does not involve HR but it 
depends on its stable association with DNA: FBH1 and other factors that inhibit 
RAD51 chromatin association promote re-replication. 
9. RAD51 associates with DNA during the S phase and acts as a molecular brake 
to limit the progression of re-replicated forks. 
10. MRE11 and possibly other nucleases are involved in the resection of re-
replicated DNA. 
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CONCLUSIONES 
 
1. En células primarias, CDC6 es un factor limitante para el licenciamiento y 
activación de los orígenes de replicación. 
2. En células primarias, la sobre-expresión simultánea de CDC6 y CDT1 conduce a 
la re-replicación parcial del genoma. 
3. La sobre-expresión de CDT1, individual o combinada con CDC6, produce re-
replicación de DNA en células del hígado fetal y resulta letal durante el 
desarrollo embrionario. 
4. Los animales adultos son resistentes a la sobre-expresión individual de CDC6 y 
CDT1 en la mayoría de los tejidos, y su esperanza de vida sólo se reduce de 
manera marginal. 
5. La sobre-expresión combinada de CDC6 y CDT1 induce re-replicación de DNA 
y displasia en varios tejidos, principalmente estómago, intestino, bazo y médula 
ósea. La displasia del epitelio intestinal resulta letal en menos de dos semanas. 
6. Los niveles endógenos de proteína CDC6 determinan la susceptibilidad celular a 
la re-replicación inducida por desregulación de CDT1. 
7. Mediante un screening genético se ha identificado que las proteínas RAD51 y 
FBH1 participan en el control de la re-replicación del DNA. 
8. La función de RAD51 en el control de la re-replicación no requiere 
recombinación homóloga pero depende de su asociación estable al DNA: FBH1 
y otros factores que inhiben su unión a cromatina promueven la re-replicación. 
9. RAD51 se une al DNA durante la fase S y parece actuar como un freno 
molecular de la progresión de las horquillas re-replicadas.  
10.  MRE11 y probablemente otras nucleasas participan en la resección del ADN re-
replicado. 
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